{"content":"<li class=\"n-box-item date-title\" data-end=\"1564199999\" data-start=\"1564113600\" data-txt=\"Monday, December 23, 2019\">Friday, July 26, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3482504\" data-ts=\"1564176743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482504-dodxf-obln-lxrx-and-mnk-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DODXF, OBLN, LXRX and MNK among notable after hour movers</a></h4><ul><li><b>Top Gainers: </b><a href='https://seekingalpha.com/symbol/DODXF' title='DEUT BK LKD DOW JONES'>OTCPK:DODXF</a> <font color=\"green\">+9.7%</font>. <a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a> <font color=\"green\">+6.6%</font>. <a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene, Ltd.'>BGNE</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color=\"green\">+4.2%</font>. <a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica Holdings, Inc.'>SLCA</a> <font color=\"green\">+4.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"red\">-47%</font>. <a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"red\">-6.6%</font>. <a href='https://seekingalpha.com/symbol/REVG' title='REV Group, Inc.'>REVG</a> <font color=\"red\">-5%</font>. <a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color=\"red\">-4.9%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color=\"red\">-3.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482504\" data-linked=\"DODXF, OBLN, LXRX and MNK among notable after hour movers\" data-tweet=\"$DODXF $OBLN $BGNE - DODXF, OBLN, LXRX and MNK among notable after hour movers https://seekingalpha.com/news/3482504-dodxf-obln-lxrx-and-mnk-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482504-dodxf-obln-lxrx-and-mnk-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482483\" data-ts=\"1564173651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482483-vxx-uvxy-ugaz-and-tvix-among-weekly-etf-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VXX, UVXY, UGAZ and TVIX among weekly ETF movers</a></h4><ul><li><strong>Gainers: </strong>Direxion Natural Gas Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>) <font color=\"green\">+15.2%</font>. Semiconductor Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>) <font color=\"green\">+14.2%</font>. Direxion Regional Banks Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DPST' title='Direxion Daily Regional Banks Bull 3x Shares ETF'>DPST</a>) <font color=\"green\">+11.4%</font>. Ultra Semiconductors Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>) <font color=\"green\">+9.1%</font>. Natural Gas -3X Inverse ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>) <font color=\"green\">+9.0%</font>.</li><li><strong>Losers: </strong>Natural Gas Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>) <font color=\"red\">-15.0%</font>. VS 2X VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a>) <font color=\"red\">-14.3%</font>. Semiconductor Bear 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>) <font color=\"red\">-13.8%</font>. Ultra VIX Short-Term Fut Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UVXY' title='ProShares Ultra VIX Short-Term Futures ETF'>UVXY</a>) <font color=\"red\">-11.5%</font>. Natural Gas 3X Long ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>) <font color=\"red\">-10.4%</font>.</li><li><strong>Top non-leveraged gainers: </strong>Dynamic Semiconductors Invesco ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>) <font color=\"green\">+5.7%</font>. S&amp;P Semiconductor SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>) <font color=\"green\">+5.0%</font>. G-X Social Media ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/SOCL' title='Global X Social Media Index ETF'>SOCL</a>) <font color=\"green\">+4.9%</font>. PHLX Semiconductor Ishares ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>) <font color=\"green\">+4.7%</font>. Dynamic Software Invesco ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/PSJ' title='Invesco Dynamic Software Portfolio ETF'>PSJ</a>) <font color=\"green\">+4.6%</font>.</li><li><strong>Top non-leveraged losers: </strong>Ipath.B S&amp;P 500 VIX Short-Term Futures ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>) <font color=\"red\">-7.8%</font>. VIX Short-Term Futures Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/VIXY' title='ProShares VIX Short-Term Futures ETF'>VIXY</a>) <font color=\"red\">-7.7%</font>. VS VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>) <font color=\"red\">-7.6%</font>. Ipatha.B Coffee Subindex TR ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/JO' title='iPath Series B Bloomberg Coffee Subindex Total Return ETN'>JO</a>) <font color=\"red\">-6.9%</font>. Advisorshares Pure Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/YOLO' title='AdvisorShares Pure Cannabis ETF'>YOLO</a>) <font color=\"red\">-6.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482483\" data-linked=\"VXX, UVXY, UGAZ and TVIX among weekly ETF movers\" data-tweet=\"$GASX $SOXL $DPST - VXX, UVXY, UGAZ and TVIX among weekly ETF movers https://seekingalpha.com/news/3482483-vxx-uvxy-ugaz-and-tvix-among-weekly-etf-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482483-vxx-uvxy-ugaz-and-tvix-among-weekly-etf-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482477\" data-ts=\"1564172655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482477-lexicon-down-32-after-hours-on-sanofi-exit-from-sotagliflozin-collaboration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon down 32% after hours on Sanofi exit from sotagliflozin collaboration</a></h4><ul><li>After mixed results in two Phase 3 studies, Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) has decided to <a href=\"https://seekingalpha.com/pr/17584507-sanofi-sanofi-provides-update-zynquistatm-sotagliflozin-type-2-diabetes-phase-3-program\" target=\"_blank\">terminate </a>its collaboration with Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) to develop, manufacture and commercialize Zynquista (sotagliflozin) for controlling blood sugar levels in type 1 and 2 diabetics.</li><li>In the <a href=\"https://clinicaltrials.gov/ct2/show/NCT02926950?intr=sotagliflozin&amp;lead=sanofi&amp;phase=2&amp;rank=6\" target=\"_blank\">SOTA-MET</a> study, Zynquista showed a statistically significant reduction in HbA1c compared to placebo at week 26 in patients on metformin.</li><li>In <a href=\"https://clinicaltrials.gov/ct2/show/NCT03242252?term=sota-ckd3&amp;rank=1\" target=\"_blank\">SOTA-CKD3</a>, Zynquista demonstrated a statistically significant reduction in HbA1c in the entire population of patients with moderate chronic kidney disease &#40;CKD&#41; and in the subpopulation of patients with kidney function just below the threshold for CKD (Stage 3A) but did not in the subpopulation with more profound CKD (Stage 3B).</li><li>In <a href=\"https://clinicaltrials.gov/ct2/show/NCT03242018?term=sota-ckd4&amp;rank=1\" target=\"_blank\">SOTA-CKD4</a>, Zynquista failed to show a statistically significant effect on HbA1c compared to control at week 26.</li><li>All ongoing Phase 3 studies will continue.</li><li>LXRX is down <font color=\"red\">32%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482477\" data-linked=\"Lexicon down 32% after hours on Sanofi exit from sotagliflozin collaboration\" data-tweet=\"$SNY $LXRX - Lexicon down 32% after hours on Sanofi exit from sotagliflozin collaboration https://seekingalpha.com/news/3482477-lexicon-down-32-after-hours-on-sanofi-exit-from-sotagliflozin-collaboration?source=tweet\" data-url=\"https://seekingalpha.com/news/3482477-lexicon-down-32-after-hours-on-sanofi-exit-from-sotagliflozin-collaboration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482464\" data-ts=\"1564171094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRTC\" target=\"_blank\">IRTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482464-shares-in-irhythm-tech-down-4-on-reimburse-code-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares in iRhythm Tech down 4% on reimburse code change</a></h4><ul><li>Thinly traded iRhythm Technologies (<a href='https://seekingalpha.com/symbol/IRTC' title='iRhythm Technologies, Inc.'>IRTC</a> <font color=\"red\">-3.8%</font>) slips on almost double normal volume in apparent response to a new permanent reimbursement code for Zio Patch that is less favorable than the temporary codes used to date. The new code may take effect as early as October 1.</li><li>Developing....</li></ul><div class=\"tiny-share-widget\" data-id=\"3482464\" data-linked=\"Shares in iRhythm Tech down 4% on reimburse code change\" data-tweet=\"$IRTC - Shares in iRhythm Tech down 4% on reimburse code change https://seekingalpha.com/news/3482464-shares-in-irhythm-tech-down-4-on-reimburse-code-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3482464-shares-in-irhythm-tech-down-4-on-reimburse-code-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482462\" data-ts=\"1564170197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWA\" target=\"_blank\">BWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482462-borgwarner-downgraded-rbc-deutsche-bank-after-dismal-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BorgWarner downgraded at RBC, Deutsche Bank after dismal guidance</a></h4><ul><li>BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color=\"red\">-2.9%</font>) drops as much as 9% following <a href=\"https://seekingalpha.com/news/3481834-borgwarner-minus-4-percent-outlook-falls-short\" target=\"_blank\">yesterday's downside profit guidance</a>, which has prompted two analyst downgrades.</li><li>RBC Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/BWAid2939380/BWA-BorgWarner-downgraded-to-Sector-Perform-from-Outperform-at-RBC-Capital\" target=\"_blank\">downgrades</a> BWA to Sector Perform from Outperform with a $41 price target, turning incrementally more negative on the stock after the Q2 results as well as acknowledgement about tougher competitor pricing on turbos.</li><li>RBC says it is intrigued by BWA's portfolio and longer-term opportunity around the industry transition from ICE to xEV, but the firm expects greater margin pressure during the transition.</li><li><a href=\"https://thefly.com/thestreet/realmoney/index.php/BWAid2939230/BWA-Deutsche-Bank-downgrades-BorgWarner-to-Hold-on-margin-growth-concerns\" target=\"_blank\">BWA also is cut</a> at Deutsche Bank to Hold from Buy with a $44 price target, as the company's update raises concerns about its growth and margin profile.</li><li>The company's lowered 2019 backlog, including virtually no net new business expected in Q2, suggests just 3% of growth above market, less than half of last year's outperformance, the firm says.</li><li>BWA's average <a href=\"https://seekingalpha.com/symbol/BWA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform and its <a href=\"https://seekingalpha.com/symbol/BWA/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bullish, while its <a href=\"https://seekingalpha.com/symbol/BWA/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482462\" data-linked=\"BorgWarner downgraded at RBC, Deutsche Bank after dismal guidance\" data-tweet=\"$BWA - BorgWarner downgraded at RBC, Deutsche Bank after dismal guidance https://seekingalpha.com/news/3482462-borgwarner-downgraded-rbc-deutsche-bank-after-dismal-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3482462-borgwarner-downgraded-rbc-deutsche-bank-after-dismal-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482457\" data-ts=\"1564169316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNG\" target=\"_blank\">UNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482457-cabot-eqt-squashed-natural-gas-sinks-to-three-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabot, EQT squashed as natural gas sinks to three-year low</a></h4><ul><li>Natural gas prices (<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color=\"red\">-2.8%</font>) typically rise along with the heat of the summer, as demand from electricity plants surges to power air conditioners... but not this year, even as the heat wave in the eastern U.S. generated record consumption at power plants.</li><li>August futures settled <font color=\"red\">-3.3%</font> to $2.169/MMBtu, a <a href=\"https://www.wsj.com/articles/the-natural-gas-market-is-in-a-summer-meltdown-11564163729\" target=\"_blank\">fresh three-year low</a> and the lowest July price since 1999, and the trauma is forcing some of the largest U.S. nat gas producers to shelve drilling plans.</li><li>\"The equity and gas markets are sending a clear message to operators to cut growth,\" EQT (<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color=\"red\">-3.3%</font>) executive committee member Kyle Derham said yesterday during the top U.S. gas producer's <a href=\"https://seekingalpha.com/article/4277704-eqt-corp-eqt-ceo-toby-rice-q2-2019-results-earnings-call-transcript\" target=\"_blank\">conference call</a> to discuss <a href=\"https://seekingalpha.com/news/3481444-eqt-eps-beats-0_06-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li>Cabot Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color=\"red\">-12.5%</font>) shares are suffering their worst one-day beating since 2008 following <a href=\"https://seekingalpha.com/news/3482249-cabot-oil-and-gas-reports-q2-beat-despite-natural-gas-price-weakness\" target=\"_blank\">Q2 results</a>, as the company says it will run just three drilling rigs and two hydraulic fracturing fleets in the current price environment; COG now sees production rising at ~5% Y/Y instead of the double-digit growth analysts have expected.</li><li>\"Gas stocks will remain broken until the industry shifts its stance on growth in both the Haynesville and Appalachia,\" Tudor Pickering Holt analysts say.</li><li>Other gas-focused names trading in the red: <a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color=\"red\">-7.8%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Company'>SWN</a> <font color=\"red\">-6.2%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"red\">-2.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3482457\" data-linked=\"Cabot, EQT squashed as natural gas sinks to three-year low\" data-tweet=\"$UNG $EQT $COG - Cabot, EQT squashed as natural gas sinks to three-year low https://seekingalpha.com/news/3482457-cabot-eqt-squashed-natural-gas-sinks-to-three-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3482457-cabot-eqt-squashed-natural-gas-sinks-to-three-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>136&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482454\" data-ts=\"1564168366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482454-trade-deskplus-7_8-on-amazon-ad-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk +7.8% on Amazon ad tie-up</a></h4><ul><li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color=\"red\">-1.7%</font>) is <a href=\"https://www.wsj.com/articles/amazon-opens-streaming-tv-ad-sales-to-outside-buying-tools-11564165476\" target=\"_blank\">letting advertisers</a> use external ad-buying tools like Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) <font color=\"green\">+7.8%</font> for advertising on its Fire TV platform in a bid to grow in a digital ad space dominated by Facebook and Alphabet.</li><li>The openness could also help Amazon appear cooperative with smaller competitors as the tech giant faces increasing global regulatory scrutiny for potential antitrust actions.</li><li>Amazon's new structure resembles that of Roku (<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a> <font color=\"green\">+3%</font>), which lets advertisers buy video ads through Adobe's ad software.</li><li>Post updated to clarify the wording in the first bullet.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482454\" data-linked=\"Trade Desk +7.8% on Amazon ad tie-up\" data-tweet=\"$AMZN $TTD $ROKU - Trade Desk +7.8% on Amazon ad tie-up https://seekingalpha.com/news/3482454-trade-deskplus-7_8-on-amazon-ad-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3482454-trade-deskplus-7_8-on-amazon-ad-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482448\" data-ts=\"1564167570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482448-carb-mxl-type-and-vcra-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CARB, MXL, TYPE and VCRA among tech movers</a></h4><ul><li><strong>Gainers</strong>: Smith Micro Software (NASDAQ:<a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a>) <font color=\"green\">+54%</font>. Monotype Imaging (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"green\">+24%</font>. GlobalSCAPE (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSB' title='GlobalSCAPE, Inc.'>GSB</a>) <font color=\"green\">+22%</font>. Exela Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/XELA' title='Exela Technologies, Inc.'>XELA</a>) <font color=\"green\">+18%</font>. SigmaTron International (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMA' title='SigmaTron International, Inc.'>SGMA</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers</strong>: Carbonite, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/CARB' title='Carbonite, Inc.'>CARB</a>) <font color=\"red\">-24%</font>.Vocera Communications (NYSE:<a href='https://seekingalpha.com/symbol/VCRA' title='Vocera Communications, Inc.'>VCRA</a>) <font color=\"red\">-9%</font>. MaxLinear (NYSE:<a href='https://seekingalpha.com/symbol/MXL' title='MaxLinear, Inc.'>MXL</a>) <font color=\"red\">-8%</font>. Vicor (NASDAQ:<a href='https://seekingalpha.com/symbol/VICR' title='Vicor Corporation'>VICR</a>) <font color=\"red\">-7%</font>. Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems, Inc.'>MITK</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482448\" data-linked=\"CARB, MXL, TYPE and VCRA among tech movers\" data-tweet=\"$SMSI $TYPE $GSB - CARB, MXL, TYPE and VCRA among tech movers https://seekingalpha.com/news/3482448-carb-mxl-type-and-vcra-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482448-carb-mxl-type-and-vcra-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482443\" data-ts=\"1564165846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482443-fb-bans-alcohol-tobacco-sales-users\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FB bans alcohol, tobacco sales between users</a></h4><ul><li>Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a> <font color='red'>-0.6%</font>) <a href=\"https://www.cnbc.com/2019/07/26/facebook-bans-sales-of-alcohol-and-tobacco-between-users.html\" target=\"_blank\">updates</a> its regulated goods policy to prohibit the sale of alcohol and tobacco products between users on both Facebook and Instagram.</li><li>The commerce policies already prohibited the sales through places like FB Marketplace, and the new rule extends the ban to \"organic content.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3482443\" data-linked=\"FB bans alcohol, tobacco sales between users\" data-tweet=\"$FB - FB bans alcohol, tobacco sales between users https://seekingalpha.com/news/3482443-fb-bans-alcohol-tobacco-sales-users?source=tweet\" data-url=\"https://seekingalpha.com/news/3482443-fb-bans-alcohol-tobacco-sales-users\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482442\" data-ts=\"1564165339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOW\" target=\"_blank\">DOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482442-dow-downgraded-baml-capping-7-two-day-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow downgraded at BAML, capping 7% two-day slide</a></h4><ul><li>Dow Inc. (<a href='https://seekingalpha.com/symbol/DOW' title='Dow Inc.'>DOW</a> <font color='red'>-3.4%</font>) slides for a second straight day as BofA Merrill Lynch <a href=\"https://thefly.com/thestreet/realmoney/index.php/DOWid2939189/DOW-Dow-Inc-downgraded-to-Neutral-from-Buy-at-BofAMerrill\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $55 price target, saying <a href=\"https://seekingalpha.com/news/3481592-dow-cites-global-uncertainty-500m-capex-guidance-cut\" target=\"_blank\">Q2 results</a> came in slightly ahead of reduced consensus estimates but the company's outlook was  \"underwhelming.\"</li><li>BAML analyst Steve Byrne says the drag on profitability from MDI,  SIloxanes and MEG has been larger than expected, and does not believe Dow will right-size the cost structure appropriately.</li><li>Byrne also believes Dow will need to inject another $500M of capital into Sadara and sees pressure on profitability well into H1 2020.</li><li>The analyst thinks investors can get better sector exposure through LyondellBassel (<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a>) at a lower valuation and with fewer distractions.</li><li>Dow's average <a href=\"https://seekingalpha.com/symbol/DOW/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform and its <a href=\"https://seekingalpha.com/symbol/DOW/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482442\" data-linked=\"Dow downgraded at BAML, capping 7% two-day slide\" data-tweet=\"$DOW $LYB - Dow downgraded at BAML, capping 7% two-day slide https://seekingalpha.com/news/3482442-dow-downgraded-baml-capping-7-two-day-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3482442-dow-downgraded-baml-capping-7-two-day-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482440\" data-ts=\"1564163984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482440-world-fuel-services-and-dril-quip-among-energy-materials-gainers-bp-prudhoe-bay-royalty-trust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World Fuel Services and Dril-Quip among Energy/Materials gainers; BP Prudhoe Bay Royalty Trust and Cabot Oil &amp; Gas among losers</a></h4><ul><li><b>Gainers: </b>World Fuel Services (NYSE:<a href='https://seekingalpha.com/symbol/INT' title='World Fuel Services Corporation'>INT</a>) <font color=\"green\">+10%</font>. Dril-Quip (NYSE:<a href='https://seekingalpha.com/symbol/DRQ' title='Dril-Quip, Inc.'>DRQ</a>) <font color=\"green\">+8%</font>. SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"green\">+8%</font>. Energy Fuels (NYSEMKT:<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc.'>UUUU</a>) <font color=\"green\">+6%</font>. Golden Star Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSS' title='Golden Star Resources Ltd.'>GSS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>BP Prudhoe Bay Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a>) <font color=\"red\">-17%</font>. Cabot Oil &amp; Gas (NYSE:<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a>) <font color=\"red\">-11%</font>. HighPoint Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>) <font color=\"red\">-8%</font>. Antero Midstream (NYSE:<a href='https://seekingalpha.com/symbol/AM' title='Antero Midstream Corporation'>AM</a>) <font color=\"red\">-8%</font>. Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482440\" data-linked=\"World Fuel Services and Dril-Quip among Energy/Materials gainers; BP Prudhoe Bay Royalty Trust and Cabot Oil &amp; Gas among losers\" data-tweet=\"$INT $DRQ $SNES - World Fuel Services and Dril-Quip among Energy/Materials gainers; BP Prudhoe Bay Royalty Trust and Cabot Oil &amp; Gas among losers https://seekingalpha.com/news/3482440-world-fuel-services-and-dril-quip-among-energy-materials-gainers-bp-prudhoe-bay-royalty-trust?source=tweet\" data-url=\"https://seekingalpha.com/news/3482440-world-fuel-services-and-dril-quip-among-energy-materials-gainers-bp-prudhoe-bay-royalty-trust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482432\" data-ts=\"1564162929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482432-former-fox-rsns-go-dark-on-dish-sling-after-extension-runs-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Former Fox RSNs go dark on Dish, Sling after extension runs out</a></h4><ul>   <li>Dish Network (DISH <font color=\"green\">+1.5%</font>) says that after a temporary extension to talks, 16 of Disney's (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color=\"green\">+1.1%</font>) acquired Fox regional sports networks have been pulled from Dish and its Sling TV.</li>    <li>The Fox RSNs (currently in the process of being sold to Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color=\"red\">-3.5%</font>)) and YES Network are \"demanding unreasonable rates and attempting to make Dish customers pay for the channels, whether they get them or not,\" Dish says in a statement.</li>    <li>Dish says it offered a short-term contract extension that would have included a retroactive rate adjustment, but that the offer was rejected.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482432\" data-linked=\"Former Fox RSNs go dark on Dish, Sling after extension runs out\" data-tweet=\"$DIS $SBGI - Former Fox RSNs go dark on Dish, Sling after extension runs out https://seekingalpha.com/news/3482432-former-fox-rsns-go-dark-on-dish-sling-after-extension-runs-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3482432-former-fox-rsns-go-dark-on-dish-sling-after-extension-runs-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482429\" data-ts=\"1564161431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBER\" target=\"_blank\">UBER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482429-uberplus-2_6-on-grocery-delivery-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber +2.6% on grocery delivery talks</a></h4><ul><li><a href=\"https://www.bloomberg.com/news/articles/2019-07-26/uber-in-talks-with-european-supermarkets-about-grocery-delivery\" target=\"_blank\"><em>Bloomberg</em> sources</a> say Uber (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) is in talks with European supermarkets including the U.K.\u2019s Sainsbury stores.</li><li>The move would catch up with rivals Deliveroo and Just Eat, which already offer grocery delivery.</li><li>Deliveroo and Sainsbury already have a partnership to deliver hot pizzas to customers in four British cities.</li><li>Uber shares are <font color=\"green\">up 2.6%</font> to $44.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482429\" data-linked=\"Uber +2.6% on grocery delivery talks\" data-tweet=\"$UBER - Uber +2.6% on grocery delivery talks https://seekingalpha.com/news/3482429-uberplus-2_6-on-grocery-delivery-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3482429-uberplus-2_6-on-grocery-delivery-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482426\" data-ts=\"1564160803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482426-semis-tech-inch-up-after-busy-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis, tech inch up after busy earnings</a></h4><ul><li>The Philadelphia Semiconductor Index <font color=\"green\">+0.2% </font>gains slightly on the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) <font color=\"green\">+0.16%</font> after Intel, Google, and Twitter reported earnings yesterday and this morning. The Nasdaq leads the afternoon, up over <font color=\"green\">1%</font>.</li><li>Semi names in the green include Cree (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='green'>+1.5%</font>), Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+1.3%</font>), and Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne, Inc.'>TER</a> <font color='green'>+1.1%</font>). Decliners include Xilinx (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color='red'>-4.3%</font>) and Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a> <font color='red'>-1.2%</font>).</li><li>Related semi ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3482426\" data-linked=\"Semis, tech inch up after busy earnings\" data-tweet=\"$XLK $CREE $NVDA - Semis, tech inch up after busy earnings https://seekingalpha.com/news/3482426-semis-tech-inch-up-after-busy-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3482426-semis-tech-inch-up-after-busy-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482425\" data-ts=\"1564160545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482425-proto-labs-only-industrial-gainer-hovnanian-enterprises-and-dmc-global-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proto Labs only industrial gainer; Hovnanian Enterprises and DMC Global among losers</a></h4><ul><li><b>Gainers: </b>Proto Labs (NYSE:<a href='https://seekingalpha.com/symbol/PRLB' title='Proto Labs, Inc.'>PRLB</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Comfort Systems USA (NYSE:<a href='https://seekingalpha.com/symbol/FIX' title='Comfort Systems USA, Inc.'>FIX</a>) <font color=\"red\">-16%</font>. DMC Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a>) <font color=\"red\">-16%</font>. ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"red\">-13%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-11%</font>. BioHiTech Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BHTG' title='BioHiTech Global, Inc.'>BHTG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482425\" data-linked=\"Proto Labs only industrial gainer; Hovnanian Enterprises and DMC Global among losers\" data-tweet=\"$PRLB $FIX $BOOM - Proto Labs only industrial gainer; Hovnanian Enterprises and DMC Global among losers https://seekingalpha.com/news/3482425-proto-labs-only-industrial-gainer-hovnanian-enterprises-and-dmc-global-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482425-proto-labs-only-industrial-gainer-hovnanian-enterprises-and-dmc-global-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482423\" data-ts=\"1564160382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482423-keybanc-sees-upside-on-tempur-sealy-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc sees upside on Tempur Sealy International</a></h4><ul> <li>KeyBanc back up its Overweight rating on Tempur Sealy International (<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International, Inc.'>TPX</a> <font color='green'>+0.6%</font>) after taking in the company's <a href=\"https://seekingalpha.com/news/3481470-tempur-sealy-sees-outperformance-north-america\" target=\"_blank\">Q2 earnings report</a>.</li> <li>The firm thinks EBITDA guidance from TPX for $75M to $100M of incremental EBITDA could be conservative and sees <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14142783/keybanc-raises-tempur-sealys-target-price-on-strong-q2-positive-outlook\" target=\"_blank\">EPS upside</a> from share buybacks.</li> <li>KeyBanc's new price target of $95 is ahead of the sell-side average PT of $88.11. Shares of Tempur Sealy traded at a 52-week high of $81.29 earlier in the session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482423\" data-linked=\"KeyBanc sees upside on Tempur Sealy International\" data-tweet=\"$TPX - KeyBanc sees upside on Tempur Sealy International https://seekingalpha.com/news/3482423-keybanc-sees-upside-on-tempur-sealy-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3482423-keybanc-sees-upside-on-tempur-sealy-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482418\" data-ts=\"1564160125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482418-ehealth-leads-financial-gainers-flexshopper-and-nmi-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">eHealth leads financial gainers, FlexShopper and NMI Holdings among losers</a></h4><ul><li><b>Gainers:</b> eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+26%</font>. Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"green\">+14%</font>. Blue Capital Reinsurance Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BCRH' title='Blue Capital Reinsurance Holdings Ltd.'>BCRH</a>) <font color=\"green\">+14%</font>. Dime Community Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/DCOM' title='Dime Community Bancshares, Inc.'>DCOM</a>) <font color=\"green\">+11%</font>. Grupo Financiero Galicia (NASDAQ:<a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Erie Indemnity (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIE' title='Erie Indemnity Company'>ERIE</a>) <font color=\"red\">-15%</font>. FlexShopper (NASDAQ:<a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a>) <font color=\"red\">-15%</font>. NMI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a>) <font color=\"red\">-6%</font>. ATIF Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIF' title='ATIF Holdings Limited'>ATIF</a>) <font color=\"red\">-5%</font>. GWG Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings, Inc.'>GWGH</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482418\" data-linked=\"eHealth leads financial gainers, FlexShopper and NMI Holdings among losers\" data-tweet=\"$EHTH $ENVA $BCRH - eHealth leads financial gainers, FlexShopper and NMI Holdings among losers https://seekingalpha.com/news/3482418-ehealth-leads-financial-gainers-flexshopper-and-nmi-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482418-ehealth-leads-financial-gainers-flexshopper-and-nmi-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482415\" data-ts=\"1564159722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482415-tech-telecom-lead-stocks-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech, telecom lead stocks higher</a></h4><ul><li>Stocks extend their gains, with the Nasdaq and S&amp;P 500 reaching new intraday highs, as Google parent Alphabet (<font color=\"green\">+10%</font>) and Twitter (<font color=\"green\">+8.8%</font>) surged after better-than-expected earnings.</li><li>And investors didn't see anything in the Q2 GDP report to change expectations for a 25-basis point rate cut when the Fed meets next week.</li><li>The Nasdaq <font color=\"green\">gains 1.0%</font> and the S&amp;P<font color=\"green\"> rises 0.6%</font>; the Dow, which has been fluctuating, is<font color=\"green\"> up 0.1%</font>.</li><li>By S&amp;P 500 sector, communications services (<font color=\"green\">+3.1%</font>) and consumer staples (<font color=\"green\">+1.1%</font>) lead the climb, while energy (<font color=\"red\">-0.6%</font>) and industrials (<font color=\"red\">-0.2%</font>) lag.</li><li>Sprint (<font color=\"green\">+6.9%</font>) and T-Mobile (<font color=\"green\">+4.7%</font>) rise after the Justice Department gives its blessing for their merger, assuming they divest Dish Network (<font color=\"green\">+2.3%</font>) to make it a national wireless competitor.</li><li>The 10-year Treasury yield is little changed at 2.075%.</li><li>Crude oil <font color=\"green\">rises 0.5%</font> to $56.30 per barrel.</li><li>Dollar Index <font color=\"green\">rises 0.2%</font> to 98.04 after reports that President Trump has ruled out currency intervention measures.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482415\" data-linked=\"Tech, telecom lead stocks higher\" data-tweet=\"Tech, telecom lead stocks higher https://seekingalpha.com/news/3482415-tech-telecom-lead-stocks-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3482415-tech-telecom-lead-stocks-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482414\" data-ts=\"1564159713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482414-gatehouse-gannett-merger-still-in-talks-come-aug-6-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GateHouse/Gannett merger still in talks, could come Aug. 6 - report</a></h4><ul>   <li>A merger between GateHouse (NYSE:<a href='https://seekingalpha.com/symbol/NEWM' title='New Media Investment Group Inc.'>NEWM</a>) and Gannett (NYSE:<a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a>) is still in discussion and could be announced with Gannett's earnings on Aug. 6, <a href=\"https://t.co/4vGHggX1QO\" target=\"_blank\">TheDeal reports</a>.</li>    <li>A source tells TheDeal that talks are ongoing.</li>    <li>Gannett has trimmed gains but is <font color=\"green\">up 0.9%</font> on the day; GateHouse owner New Media Investment Group is <font color=\"green\">up 1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482414\" data-linked=\"GateHouse/Gannett merger still in talks, could come Aug. 6 - report\" data-tweet=\"$NEWM $GCI - GateHouse/Gannett merger still in talks, could come Aug. 6 - report https://seekingalpha.com/news/3482414-gatehouse-gannett-merger-still-in-talks-come-aug-6-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3482414-gatehouse-gannett-merger-still-in-talks-come-aug-6-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482411\" data-ts=\"1564159296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482411-erie-ehth-snbr-and-mmsi-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ERIE, EHTH, SNBR and MMSI among midday movers</a></h4><ul><li><strong>Gainers: </strong>Smith Micro Software (NASDAQ:<a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a>) <font color=\"green\">+42%</font>. Harvard Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/HBIO' title='Harvard Bioscience, Inc.'>HBIO</a>) <font color=\"green\">+38%</font>. Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences Inc.'>SLDB</a>) <font color=\"green\">+31%</font>. GlobalSCAPE (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSB' title='GlobalSCAPE, Inc.'>GSB</a>) <font color=\"green\">+29%</font>. LiveXLive Media (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVX' title='LiveXLive Media, Inc.'>LIVX</a>) <font color=\"green\">+27%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+26%</font>. Achillion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a>) <font color=\"green\">+24%</font>. Monotype Imaging Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"green\">+24%</font>. Sleep Number Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>) <font color=\"green\">+18%</font>. Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"green\">+18%</font>.</li>  <li><strong>Losers: </strong>Neuralstem (NASDAQ:<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a>) <font color=\"red\">-37%</font>. Merit Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a>) <font color=\"red\">-27%</font>. Carbonite (NASDAQ:<a href='https://seekingalpha.com/symbol/CARB' title='Carbonite, Inc.'>CARB</a>) <font color=\"red\">-24%</font>. DMC Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a>) <font color=\"red\">-17%</font>. BP Prudhoe Bay Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a>) <font color=\"red\">-16%</font>. Erie Indemnity Company (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIE' title='Erie Indemnity Company'>ERIE</a>) <font color=\"red\">-15%</font>. Comfort Systems (NYSE:<a href='https://seekingalpha.com/symbol/FIX' title='Comfort Systems USA, Inc.'>FIX</a>) <font color=\"red\">-16%</font>. Mohawk Industries (NYSE:<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries, Inc.'>MHK</a>) <font color=\"red\">-15%</font>. USA Truck (NASDAQ:<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a>) <font color=\"red\">-15%</font>. FlexShopper (NASDAQ:<a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482411\" data-linked=\"ERIE, EHTH, SNBR and MMSI among midday movers\" data-tweet=\"$SMSI $HBIO $SLDB - ERIE, EHTH, SNBR and MMSI among midday movers https://seekingalpha.com/news/3482411-erie-ehth-snbr-and-mmsi-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482411-erie-ehth-snbr-and-mmsi-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482410\" data-ts=\"1564159240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCN\" target=\"_blank\">WCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482410-waste-connections-names-worthing-jackman-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waste Connections names Worthing Jackman as CEO</a></h4><ul><li>Waste Connections (<a href='https://seekingalpha.com/symbol/WCN' title='Waste Connections, Inc.'>WCN</a> <font color=\"green\">+1%</font>) has <a href=\"https://seekingalpha.com/pr/17584082-waste-connections-names-worthing-jackman-president-ceo-ron-mittelstaedt-transitions-executive\" target=\"_blank\">appointed</a> Worthing F. Jackman, as President and Chief Executive Officer. He has also joined Board of Directors.</li><li>Mr. Jackman joined Waste Connections in 2003 and assumed the role of CFO in 2004. He was promoted to President in July 2018 and has served as the Company's Principal Executive Officer since February 2019.</li><li>The Company also announced that Ronald J. Mittelstaedt has returned from his temporary leave of absence and assumed the role of Executive Chairman of the Board of Directors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482410\" data-linked=\"Waste Connections names Worthing Jackman as CEO\" data-tweet=\"$WCN - Waste Connections names Worthing Jackman as CEO https://seekingalpha.com/news/3482410-waste-connections-names-worthing-jackman-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3482410-waste-connections-names-worthing-jackman-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482409\" data-ts=\"1564159031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482409-teck-resources-proposed-huge-oil-sands-project-deemed-in-public-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources&#39; proposed huge oil sands project deemed in the public interest</a></h4><ul><li>A Canadian federal-provincial panel says Teck Resources' (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color=\"red\">-1.9%</font>) proposed 260K bbl/day Frontier oil sands project in Alberta would be <a href=\"https://business.financialpost.com/commodities/teck-resources-260000-bpd-oilsands-mine-in-public-interest-despite-significant-adverse-effects-panel\" target=\"_blank\">in the public interest</a>, even though it likely would significantly harm the environment and indigenous people.</li><li>The panel's report includes several dozen recommended conditions, include mitigating harm to wildlife, monitoring pollutants and taking into account feedback from nearby First Nations.</li><li>The panel also says the federal government could reap C$12B in taxes and Alberta could accumulate C$55B, with another C$3.5B in municipal property taxes, over the project's projected 41-year lifespan.</li><li>Environmental groups question how allowing the project would  square with Canada's plans to cut greenhouse gas emissions; Teck estimates the mine would emit 4.1 megatonnes of carbon dioxide per year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482409\" data-linked=\"Teck Resources&#39; proposed huge oil sands project deemed in the public interest\" data-tweet=\"$TECK - Teck Resources&#39; proposed huge oil sands project deemed in the public interest https://seekingalpha.com/news/3482409-teck-resources-proposed-huge-oil-sands-project-deemed-in-public-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3482409-teck-resources-proposed-huge-oil-sands-project-deemed-in-public-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482408\" data-ts=\"1564158732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482408-achillion-adds-to-achminus-5228-stoked-rally-shares-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achillion adds to ACH-5228-stoked rally, shares up 24%</a></h4><ul><li>Achillion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color=\"green\">+24.4%</font>) is up on a 6x surge in volume. Shares have rallied <font color=\"green\">102%</font> this week after it <a href=\"https://seekingalpha.com/news/3479616-achillion-3-percent-premarket-positive-achminus-5228-data\" target=\"_blank\">announced</a> encouraging Phase 1 data on complement factor D inhibitor candidate <a href=\"https://www.achillion.com/pipeline/\" target=\"_blank\">ACH-5228</a>.</li><li>Results showed that the higher doses (120 mg - 200 mg twice-daily) achieved near-complete and sustained Alternative Pathway &#40;AP&#41; inhibition.</li><li>Factor D, originally identified as adipsin, is an essential enzyme (serine protease) in the AP of the complement system (part of the innate immune system). Inhibiting AP may have potential in treating complement system-related disorders like paroxysmal nocturnal hemoglobinuria &#40;PNH&#41;, C3 glomerulopathy (kidneys malfunction leading to excess levels of protein in urine) and immune complex-mediated membranoproliferative glomerulonephritis (kidney malfunction due to inflammation of tiny filters called glomeruli).</li></ul><div class=\"tiny-share-widget\" data-id=\"3482408\" data-linked=\"Achillion adds to ACH-5228-stoked rally, shares up 24%\" data-tweet=\"$ACHN - Achillion adds to ACH-5228-stoked rally, shares up 24% https://seekingalpha.com/news/3482408-achillion-adds-to-achminus-5228-stoked-rally-shares-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3482408-achillion-adds-to-achminus-5228-stoked-rally-shares-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482407\" data-ts=\"1564158545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482407-tilson-eyes-big-drop-in-spirit-airlines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilson eyes big drop in Spirit Airlines</a></h4><ul> <li>Empire Financial Daily's Whitney Tilson is out with a tip on Spirit Airlines (NYSE:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a>) following the airline stock's <a href=\"https://seekingalpha.com/news/3481679-airline-stocks-sized-earnings-pour\" target=\"_blank\">24% shellacking</a> yesterday.</li> <li>Tilson reminds that every time over the last four years that SAVE has dropped to the mid-$30s it has quickly rebounded to the mid-$50s.</li> <li>Shares of Spirit Airlines have fought back a bit today with a <font color=\"green\">3.12% gain</font> to clear $43 again.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3482407\" data-linked=\"Tilson eyes big drop in Spirit Airlines\" data-tweet=\"$SAVE - Tilson eyes big drop in Spirit Airlines https://seekingalpha.com/news/3482407-tilson-eyes-big-drop-in-spirit-airlines?source=tweet\" data-url=\"https://seekingalpha.com/news/3482407-tilson-eyes-big-drop-in-spirit-airlines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482406\" data-ts=\"1564158293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HFWA\" target=\"_blank\">HFWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482406-heritage-financial-loses-bull-sharesminus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heritage Financial loses a bull; shares -1.5%</a></h4><ul><li>Janney analyst Timothy Coffey cuts Heritage Financial (<a href='https://seekingalpha.com/symbol/HFWA' title='Heritage Financial Corporation'>HFWA</a> <font color='red'>-1.5%</font>) to neutral from buy on the basis that its disappointing Q2 earnings don't \"appear to be a one-off\", he wrote in a note.</li><li>Issues, including higher-than-expected expenses and an increase in non-performing loans, could persist in a lower interest rate environment.</li><li>Quant rating<a href=\"https://seekingalpha.com/symbol/HFWA/ratings/quant-ratings\" target=\"_blank\"> Very Bearish</a>; before this action Sell-Side average rating was <a href=\"https://seekingalpha.com/symbol/HFWA/ratings/sell-side-ratings\" target=\"_blank\">Outperform</a> (2 Buy, 1 Outperform, 4 Hold).</li><li>See<a href=\"https://seekingalpha.com/symbol/HFWA/earnings/eps_surprise_summary\" target=\"_blank\"> Heritage Financial's history of earnings surprises</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481576-heritage-financial-eps-misses-0_06-misses-revenue\" target=\"_blank\">Heritage Financial EPS misses by $0.06, misses on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482406\" data-linked=\"Heritage Financial loses a bull; shares -1.5%\" data-tweet=\"$HFWA - Heritage Financial loses a bull; shares -1.5% https://seekingalpha.com/news/3482406-heritage-financial-loses-bull-sharesminus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3482406-heritage-financial-loses-bull-sharesminus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482404\" data-ts=\"1564158086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAUKF\" target=\"_blank\">AAUKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482404-anglo-american-hit-agarwals-stake-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anglo American hit by Agarwal&#39;s stake sale</a></h4><ul><li>Anglo American (<a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a> <font color=\"red\">-5.2%</font>) tumbles 4% in London after the miner's largest shareholder, Indian tycoon Anil Agarwal, said he would <a href=\"https://www.ft.com/content/b70b051c-aefa-11e9-8030-530adfa879c2\" target=\"_blank\">sell his ~20% stake</a> in the company.</li><li>The move ends speculation that Agarwal eventually would make a bid for the entire company; he had pushed Anglo to refocus on South Africa and position itself for new opportunities in India.</li><li>While Agarwal's exit puts short-term pressure on Anglo shares, it also <a href=\"https://www.wsj.com/articles/mining-industrys-34-billion-question-answered-indian-tycoon-isnt-buying-anglo-american-11564147170\" target=\"_blank\">removes a level of uncertainty</a> about his plans for the mining giant, Jefferies analyst Christopher LaFemina says, as some investors were \"concerned about Agarwal's interest being an overhang on these shares due to the uncertainty regarding his intentions.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3482404\" data-linked=\"Anglo American hit by Agarwal&#39;s stake sale\" data-tweet=\"$AAUKF $NGLOY $AAUKY - Anglo American hit by Agarwal&#39;s stake sale https://seekingalpha.com/news/3482404-anglo-american-hit-agarwals-stake-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3482404-anglo-american-hit-agarwals-stake-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482402\" data-ts=\"1564157810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482402-dish-speaks-on-wireless-merger-ok-fccs-pai-moving-on-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish speaks on wireless merger OK; FCC&#39;s Pai moving on deal</a></h4><ul>   <li>With the merger of Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+6.2%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+3.9%</font>) pas<a href=\"https://seekingalpha.com/news/3482391-doj-formally-oks-dish-deal-enable-sprint-t-mobile-merger\" target=\"_blank\">sing muster at the Justice Dept.</a>, Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+1.8%</font>) is <a href=\"https://seekingalpha.com/pr/17584330-dish-become-national-facilities-based-wireless-carrier\" target=\"_blank\">speaking out on its ambitions</a> to become the fourth player in U.S. wireless.</li>    <li>\"These developments are the fulfillment of more than two decades' worth of work and more than $21B in spectrum investments intended to transform Dish into a connectivity company,\" Dish Chairman Charlie Ergen says.</li>    <li>\"Taken together, these opportunities will set the stage for our entry as the nation's fourth facilities-based wireless competitor and accelerate our work to launch the country's first standalone 5G broadband network.\"</li>    <li>Dish notes it's committed to the FCC that it will deploy a facilities-based 5G broadband network capable of serving 70% of the U.S. population by June 2023, and it's requested (and will receive) license modifications to reflect that timeline.</li>    <li>Dish's $5B payment values Sprint's prepaid businesses at $1.4B, and $3.6B to buy Sprint's nationwide 800 MHz airwaves.</li>    <li>FCC Chairman Ajit Pai suggests he's moving forward with <a href=\"https://docs.fcc.gov/public/attachments/DOC-358721A1.pdf\" target=\"_blank\">his agency clearing the deal</a>: \u201cBecause of this transaction\u2019s potential to help close the digital divide in rural America and maintain our nation\u2019s leadership in 5G, as well as the commitments made by T-Mobile and Sprint to the FCC, I plan to present my colleagues soon with a draft order, consistent with the Department\u2019s filings, favorably resolving the FCC\u2019s review of the transaction.\u201d</li>    <li>According to signals from the majority members, that draft order would have the three votes it needs for approval.</li>    <li>Meanwhile, shares in T-Mobile parent Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"green\">+1.8%</font>) have jumped to session highs in OTC trading, as have those of SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color=\"green\">+4%</font>).</li>   <li>And in the top two U.S. wireless rivals, AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is <font color=\"green\">up 1%</font> and Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a>) is <font color=\"green\">up 1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482402\" data-linked=\"Dish speaks on wireless merger OK; FCC&#39;s Pai moving on deal\" data-tweet=\"$T $VZ $S - Dish speaks on wireless merger OK; FCC&#39;s Pai moving on deal https://seekingalpha.com/news/3482402-dish-speaks-on-wireless-merger-ok-fccs-pai-moving-on-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3482402-dish-speaks-on-wireless-merger-ok-fccs-pai-moving-on-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482399\" data-ts=\"1564157000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482399-mattel-and-vector-group-among-consumer-gainers-goodyear-tire-rubber-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel and Vector Group among consumer gainers; The Goodyear Tire &amp; Rubber among the losers</a></h4><ul><li><b>Gainers: </b>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>) <font color=\"green\">+16%</font>. Vector Group (NYSE:<a href='https://seekingalpha.com/symbol/VGR' title='Vector Group Ltd.'>VGR</a>) <font color=\"green\">+14%</font>. Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) <font color=\"green\">+10%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+6%</font>. Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Mohawk Industries (NYSE:<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries, Inc.'>MHK</a>) <font color=\"red\">-14%</font>. Deckers Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>) <font color=\"red\">-12%</font>. The Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482399\" data-linked=\"Mattel and Vector Group among consumer gainers; The Goodyear Tire &amp; Rubber among the losers\" data-tweet=\"$SNBR $VGR $MAT - Mattel and Vector Group among consumer gainers; The Goodyear Tire &amp; Rubber among the losers https://seekingalpha.com/news/3482399-mattel-and-vector-group-among-consumer-gainers-goodyear-tire-rubber-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482399-mattel-and-vector-group-among-consumer-gainers-goodyear-tire-rubber-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482393\" data-ts=\"1564155987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482393-j-c-penney-looks-to-clear-1-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney looks to clear $1 again</a></h4><ul> <li>The clock is ticking at J.C. Penney JCP (<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a>) with the stock trading under $1.00 for a full week now.</li> <li>The retailer could fall out of compliance with the New York Stock Exchange if that streak extends to 30 days or longer. A stock split is one option on the table if the share price doesn't improve.</li> <li>Things aren't at a standstill at the company. The Dallas Morning News <a href=\"https://www.dallasnews.com/business/retail/2019/07/26/jc-penneys-turnaround-stand\" target=\"_blank\">reports</a> that J.C. Penney boss Jill Soltau and CFO Bill Wafford have met with bond investors to chart a path forward on the debt payment front. Last week, Soltau \"boldly\" declared the JCP has not retained any bankruptcy advisers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482393\" data-linked=\"J.C. Penney looks to clear $1 again\" data-tweet=\"$JCP - J.C. Penney looks to clear $1 again https://seekingalpha.com/news/3482393-j-c-penney-looks-to-clear-1-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3482393-j-c-penney-looks-to-clear-1-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482392\" data-ts=\"1564155922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYDY\" target=\"_blank\">CYDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482392-cytodyn-inks-deal-to-sell-paminus-14-pro-140-for-ccr5-for-diagnostic-use\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytoDyn inks deal to sell PA-14 or PRO 140 for CCR5 for diagnostic use</a></h4><ul><li>CytoDyn (<a href='https://seekingalpha.com/symbol/CYDY' title='CytoDyn Inc.'>OTCQB:CYDY</a> <font color=\"red\">-11.7%</font>) executes a <a href=\"https://seekingalpha.com/pr/17583983-cytodyn-executes-exclusive-worldwide-licensing-agreement-incelldx-paminus-14-pro-140\" target=\"_blank\">license agreement</a> with IncellDX providing the latter with exclusive global rights to sell non-commercial grade quantities of PA-14 (the murine version of PRO 140 for diagnostic use) or PRO 140 for use in the development and commercialization of diagnostic tests for the quantitative measurement of CCR5 in human cells.</li><li>Under the terms of the deal, IncellDX will responsible for all costs associated with assay development, regulatory clearance, labeling, packaging and commercialization. Financial terms are not disclosed.</li><li>PRO 140 (leronlimab) inhibits (binds to) a protein on the surface of certain immune cells called Cysteine-Cysteine Chemokine Receptor 5 (CCR5) which plays a key role in modulating immune cell trafficking in sites of inflammation. The company says it could potentially treat graft-versus-host disease and other inflammatory conditions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482392\" data-linked=\"CytoDyn inks deal to sell PA-14 or PRO 140 for CCR5 for diagnostic use\" data-tweet=\"$CYDY - CytoDyn inks deal to sell PA-14 or PRO 140 for CCR5 for diagnostic use https://seekingalpha.com/news/3482392-cytodyn-inks-deal-to-sell-paminus-14-pro-140-for-ccr5-for-diagnostic-use?source=tweet\" data-url=\"https://seekingalpha.com/news/3482392-cytodyn-inks-deal-to-sell-paminus-14-pro-140-for-ccr5-for-diagnostic-use\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482389\" data-ts=\"1564155508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/B\" target=\"_blank\">B</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482389-barnes-slides-5-post-q2-results-miss-lowers-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes slides 5% post Q2 results miss; lowers FY19 guidance</a></h4><ul><li>Barnes Group (<a href='https://seekingalpha.com/symbol/B' title='Barnes Group Inc.'>B</a> <font color=\"red\">-5.4%</font>) reported reports Q2 sales of $376.67M (-1% Y/Y); and organic sales decrease of 4% Y/Y.</li><li>Industrial segment sales $233.4M (-6.5% Y/Y); and operating margin of 11.8% <font color=\"red\">down by 360 bps</font>.</li><li>Aerospace segment sales $138.27M (+10% Y/Y); and operating margin of 21.4% <font color=\"green\">up by 110 bps</font>. Aerospace OEM backlog was $791M (-2% Q/Q).</li><li>Q2 Operating margin<font color=\"red\"> declined by 170 bps</font> to 15.3%; and adj. operating margin <font color=\"red\">declined by 130 bps </font>to 15.7%.</li><li>SG&amp;A expenses were $76.41M (+3.5% Y/Y) and as percentage of sales 20.6% up by 89 bps.</li><li>Net cash provided by operating activities YTD was $108.16M, compared to $88.58M a year ago; and FCF of $82.72M.</li><li>Company says ongoing trade uncertainties and challenging end markets have persisted into Q2 leading to the deferral of customer new program launches in a number of their higher margin Industrial businesses.</li><li><strong>FY19 Guidance, lowered</strong>: Net sales growth ~3% to 4% (prior 4% to 6%); Adj. operating margin of 15.5% to 16%; EPS $3.10 to $3.20 (prior $3.15 to $3.27); and Adj. EPS $3.18 to $3.28 (prior $3.23 to $3.35).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3482181-barnes-group-eps-misses-0_03-misses-revenue\" target=\"_blank\">Barnes Group EPS misses by $0.03, misses on revenue</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482389\" data-linked=\"Barnes slides 5% post Q2 results miss; lowers FY19 guidance\" data-tweet=\"$B - Barnes slides 5% post Q2 results miss; lowers FY19 guidance https://seekingalpha.com/news/3482389-barnes-slides-5-post-q2-results-miss-lowers-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3482389-barnes-slides-5-post-q2-results-miss-lowers-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482391\" data-ts=\"1564155494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482391-doj-formally-oks-dish-deal-to-enable-sprint-t-mobile-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOJ formally OKs Dish deal to enable Sprint/T-Mobile merger</a></h4><ul>   <li>The deal is secured: In a release, the Justice Dept. says that it's <a href=\"https://www.justice.gov/opa/pr/justice-department-settles-t-mobile-and-sprint-their-proposed-merger-requiring-package\" target=\"_blank\">OK with a $26.5B merger</a> of Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) and T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>), contingent on the two divesting assets to make Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) into a viable national wireless competitor.</li>    <li>Sprint is <font color=\"green\">up 5.6%</font>; T-Mobile <font color=\"green\">up 3%</font>; Dish is <font color=\"green\">up 2.4%</font>.</li>    <li>The DOJ and attorneys general for five states came to a settlement with T-Mobile and Sprint; notably, that excludes the 13 attorneys general who still have a suit pending to block the deal.</li>    <li>\u201cWith this merger and accompanying divestiture, we are expanding output significantly by ensuring that large amounts of currently unused or underused spectrum are made available to American consumers in the form of high quality 5G networks,\u201d antitrust chief Makan Delrahim says.</li>    <li>Dish will pay $5B to take over Boost Mobile, Virgin Mobile and Sprint prepaid, and some airwaves to add to its own spectrum hoard, clearing what were key DOJ objections over Sprint/T-Mobile's combined power position in the prepaid wireless market.</li>    <li>T-Mobile and Sprint must make available to Dish at least 20,000 cell sites and hundreds of retail locations.</li>    <li><a href=\"https://seekingalpha.com/news/3480584-dish-agrees-5b-deal-sprint-t-mobile-assets-breakthrough-bloomberg\" target=\"_blank\">As reported</a>, the deal also contains provisions to prevent Dish from selling the assets or handing over control of the agreement to a third party, for three years. Dish gets a seven-year wholesale deal to resell T-Mobile service under its brand along with a three-year operational support agreement.</li>    <li>The merger had previously received signs of support from the GOP majority at the FCC as well, making that agency's approval a formality.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482391\" data-linked=\"DOJ formally OKs Dish deal to enable Sprint/T-Mobile merger\" data-tweet=\"$S $TMUS $DISH - DOJ formally OKs Dish deal to enable Sprint/T-Mobile merger https://seekingalpha.com/news/3482391-doj-formally-oks-dish-deal-to-enable-sprint-t-mobile-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3482391-doj-formally-oks-dish-deal-to-enable-sprint-t-mobile-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482384\" data-ts=\"1564154328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIB\" target=\"_blank\">BIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482384-drug-pricing-bill-passes-senate-committee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug pricing bill passes Senate committee</a></h4><ul><li>By a 19-9 vote, the Prescription Drug Pricing Reduction Act has <a href=\"https://www.washingtonexaminer.com/policy/healthcare/following-disputes-drug-pricing-bill-moves-out-of-senate-finance-committee\" target=\"_blank\">advanced </a>out of the Senate Finance Committee and will go before the full Senate this fall. The bill would cap out-of-pocket costs for medicines at $3,100 per year for Medicare beneficiaries beginning in 2022 and require drug makers to rebate Medicare if they hike prices above inflation.</li><li>Republicans tried to throw out the inflation provision but failed on a 14-14 vote.</li><li>Democrats tried to include a provision allowing the government to set drug prices but failed on a 12-16 vote.</li><li>House Speaker Nancy Pelosi says Democrats in the lower chamber plan to introduce a drug pricing measure in September, casting doubt on whether the House will take up the Senate version.</li><li>Predictably, the drug industry's main lobby group, the Pharmaceutical Research and Manufacturers of America, is opposed and spent more than $16M in H1 lobbying Congress and members of the Trump administration.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a>, <a href='https://seekingalpha.com/symbol/GRX' title='The Gabelli Healthcare & Wellness Rx Trust'>GRX</a>, <a href='https://seekingalpha.com/symbol/THW' title='Tekla World Healthcare Fund'>THW</a>, <a href='https://seekingalpha.com/symbol/BME' title='BlackRock Health Sciences Trust'>BME</a>, <a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a>, <a href='https://seekingalpha.com/symbol/IXJ' title='iShares Global Healthcare ETF'>IXJ</a>, <a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a>, <a href='https://seekingalpha.com/symbol/CHNA' title='The Loncar China BioPharma ETF'>CHNA</a>, <a href='https://seekingalpha.com/symbol/IDNA' title='iShares Genomics Immunology and Healthcare ETF'>IDNA</a>, <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a></li><li>Selected tickers: AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+2.1%</font>), Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"green\">+1.1%</font>), Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.5%</font>), Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"red\">-0.7%</font>), Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"green\">+1.1%</font>), Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-0.1%</font>), Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-1.3%</font>), Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-0.1%</font>), Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"green\">+2.1%</font>), Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-0.3%</font>), Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-0.1%</font>), Bausch Health Companies (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"green\">+0.4%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+0.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482384\" data-linked=\"Drug pricing bill passes Senate committee\" data-tweet=\"$BIB $GRX $THW - Drug pricing bill passes Senate committee https://seekingalpha.com/news/3482384-drug-pricing-bill-passes-senate-committee?source=tweet\" data-url=\"https://seekingalpha.com/news/3482384-drug-pricing-bill-passes-senate-committee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>137&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482383\" data-ts=\"1564154309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482383-sps-commerce-rallies-10_9-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SPS Commerce rallies 10.9% post Q2 results</a></h4><ul><li>SPS Commerce (<a href='https://seekingalpha.com/symbol/SPSC' title='SPS Commerce, Inc.'>SPSC</a> <font color=\"green\">+10.9%</font>) reports <a href=\"https://seekingalpha.com/pr/17583610-sps-commerce-reports-second-quarter-2019-financial-results\" target=\"_blank\">Q2</a> revenue growth of 12.2% Y/Y to $68.53M.</li><li>Overall Q2 margin: Gross <font color=\"red\">declined 121 bps</font> to 65.4%; operating <font color=\"green\">increased 376 bps</font> to 13.6% &amp; Adj. EBITDA <font color=\"green\">increased 414 bps</font> to 23.9%.</li><li>In Q2, the Company approved a 2-for-1 split of all outstanding shares increasing the number of shares from ~18.1M to ~36.2M.</li><li><b>Q3 2019 Guidance:</b> Revenue of $69.7-70.2M; EPS $0.37-0.39 with fully diluted weighted average shares outstanding of ~18.1M or $0.19-$0.20 on split adj. basis; Adj. EPS $0.55-0.56 or $0.27-$0.28 on a split adj. basis; Adj. EBITDA of $16.9-17.4M; SBC ~$3.2M; depreciation ~$2.9M and amortization ~$1.3M.</li><li><b>2019 Guidance:</b> Revenue of $276.6-277.7M; EPS $1.62-1.67 with fully diluted weighted average shares outstanding of ~18.1M or $0.81-$0.84 on a split adj. basis; Adj. EPS $2.30-2.35 or $1.15-$1.18 on a split adj. basis; Adj. EBITDA of $67.2-68.3M; SBC ~$14.7M; depreciation ~$11.2M and amortization ~$5.2M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481984-sps-commerce-eps-beats-0_07-beats-revenue\" target=\"_blank\">SPS Commerce EPS beats by $0.07, beats on revenue</a> (Jul. 25 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482383\" data-linked=\"SPS Commerce rallies 10.9% post Q2 results\" data-tweet=\"$SPSC - SPS Commerce rallies 10.9% post Q2 results https://seekingalpha.com/news/3482383-sps-commerce-rallies-10_9-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3482383-sps-commerce-rallies-10_9-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482379\" data-ts=\"1564153343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482379-canntrust-holdings-and-avinger-among-healthcare-gainers-neuralstem-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust Holdings and Avinger among healthcare gainers; Neuralstem leads the losers</a></h4><ul><li><b>Gainers: </b>Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences Inc.'>SLDB</a>) <font color=\"green\">+34%</font>. Harvard Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/HBIO' title='Harvard Bioscience, Inc.'>HBIO</a>) <font color=\"green\">+27%</font>. Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+15%</font>. CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"green\">+14%</font>. Avinger (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger, Inc.'>AVGR</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Neuralstem (NASDAQ:<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a>) <font color=\"red\">-38%</font>. Merit Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a>) <font color=\"red\">-26%</font>. Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals, Inc.'>MRNS</a>) <font color=\"red\">-9%</font>. Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"red\">-9%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482379\" data-linked=\"CannTrust Holdings and Avinger among healthcare gainers; Neuralstem leads the losers\" data-tweet=\"$SLDB $HBIO $RHE - CannTrust Holdings and Avinger among healthcare gainers; Neuralstem leads the losers https://seekingalpha.com/news/3482379-canntrust-holdings-and-avinger-among-healthcare-gainers-neuralstem-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482379-canntrust-holdings-and-avinger-among-healthcare-gainers-neuralstem-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482377\" data-ts=\"1564153198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482377-trinetplus-5_8-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TriNet +5.8% post Q2 results</a></h4><ul><li>TriNet (<a href='https://seekingalpha.com/symbol/TNET' title='TriNet Group, Inc.'>TNET</a> <font color=\"green\">+5.8%</font>) reports <a href=\"https://seekingalpha.com/pr/17583691-trinet-announces-second-quarter-2019-results\" target=\"_blank\">Q2</a> total revenues increase of 10% Y/Y to $935M and net service revenues increase of 5%Y/Y to $231M.</li><li>Total WSEs increased 2% Y/Y, at ~324K; Average WSEs increased 2% Y/Y, at ~319K &amp; Total WSEs payroll and payroll taxes processed was $9.1M (+9% Y/Y).</li><li>Net Insurance Service Revenues consisted of insurance service revenues of $808M, less insurance costs of $704M.</li><li>Operating margin <font color=\"red\">declined 306 bps</font> to 5.9% &amp; Adj. EBITDA also <font color=\"red\">declined 900 bps</font> to 36%.</li><li>Net Insurance Service Revenue margin <font color=\"red\">declined 100 bps</font> to 13%.</li><li>Professional service revenues increased 11% Y/Y, and Net Insurance Service Revenues decreased 2% Y/Y.</li><li>Cash and equivalents of $219M and total debt of $402M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3482000-trinet-eps-line-beats-revenue\" target=\"_blank\">TriNet EPS in-line, beats on revenue</a> (Jul. 25 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482377\" data-linked=\"TriNet +5.8% post Q2 results\" data-tweet=\"$TNET - TriNet +5.8% post Q2 results https://seekingalpha.com/news/3482377-trinetplus-5_8-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3482377-trinetplus-5_8-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482374\" data-ts=\"1564152638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOOM\" target=\"_blank\">BOOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482374-dmc-globalminus-11-despite-q2-results-beat-and-improved-margins-lowers-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DMC Global -11% despite Q2 results beat and improved margins; lowers FY19 guidance</a></h4><ul><li>DMC Global (<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a> <font color=\"red\">-11.6%</font>) reported YoY revenue growth of 10.8% in Q2 to $110.95M, driven by stronger sales at both DynaEnergetics and NobelClad business.</li><li>DynaEnergetics sales $88.63M (+50% Y/Y); gross margin was 41% <font color=\"green\">up by 408 bps</font>; and Adj. EBITDA of $28.53M (+107% Y/Y).</li><li>NobelClad sales $22.33M (+1% Y/Y); gross margin of 26.4% <font color=\"green\">up by 310 bps</font>; and Adj. EBITDA of $3.08M (+13% Y/Y).</li><li>Q2 Gross margin <font color=\"green\">improved by 483 bps</font> to 37.9%, due to a more favorable product mix and improved manufacturing and supply chain efficiencies at DynaEnergetics.</li><li>Q2 operating margin<font color=\"green\"> improved by 958 bps</font> to 22.2%.</li><li>Q2 Adj. EBITDA was $29.03M (+108.5% Y/Y); and margin <font color=\"green\">improved by 895 bps</font> to 26.2%.</li><li>Net cash provided by operating activities for the quarter was $16.31M, compared to $1.4M a year ago.</li><li><strong>3Q19 Guidance:</strong> Sales $96M to $102M; gross margin in the range of 35.5% to 36.5%; SG&amp;A expenses of $~17.5M; and Adj. EBITDA $20M to $$24M.</li><li><strong>FY19 Guidance, lowered:</strong> Sales $400M to $415M (prior $405M to $425M); Adj. EPS $3.55 to $3.70 (prior $3.40 to $3.70); Gross margin in a range of 36% to 37% (prior ~34%); SG&amp;A expenses $64M to $67M (prior ~$63M); Adj. EBITDA $90M to $100M; and Capex ~$30M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481909-dmc-global-eps-beats-0_31-beats-revenue\" target=\"_blank\">DMC Global EPS beats by $0.31, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482374\" data-linked=\"DMC Global -11% despite Q2 results beat and improved margins; lowers FY19 guidance\" data-tweet=\"$BOOM - DMC Global -11% despite Q2 results beat and improved margins; lowers FY19 guidance https://seekingalpha.com/news/3482374-dmc-globalminus-11-despite-q2-results-beat-and-improved-margins-lowers-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3482374-dmc-globalminus-11-despite-q2-results-beat-and-improved-margins-lowers-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482370\" data-ts=\"1564152233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATBPF\" target=\"_blank\">ATBPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482370-antibe-readies-7m-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antibe readies $7M equity offering</a></h4><ul><li>Antibe Therapeutics (<a href='https://seekingalpha.com/symbol/ATBPF' title='Antibe Therapeutics Inc.'>OTCQB:ATBPF</a> <font color=\"green\">+1.5%</font>) <a href=\"https://seekingalpha.com/pr/17583879-antibe-therapeutics-announces-size-offering\" target=\"_blank\">announces </a>that its $7M capital raise will be ~23.3M Units at $0.30 per Unit.</li><li>Each Unit will consist of one common share and 1/2 of a three-year warrant to purchase one common share at $0.40.</li><li>Net proceeds will fund the advancement of ATB-346.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482370\" data-linked=\"Antibe readies $7M equity offering\" data-tweet=\"$ATBPF - Antibe readies $7M equity offering https://seekingalpha.com/news/3482370-antibe-readies-7m-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3482370-antibe-readies-7m-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482369\" data-ts=\"1564152184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482369-transocean-wins-five-rig-deals-adding-158m-to-backlog\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean wins five rig deals, adding $158M to backlog</a></h4><ul><li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-2.3%</font>) unveils three new contract awards and a pair of  extensions in its latest <a href=\"https://seekingalpha.com/pr/17583682-transocean-ltd-provides-quarterly-fleet-status-report\" target=\"_blank\">fleet status report</a>, adding $158M to the company's backlog for a total of $11.4B.</li><li>In Canada, RIG <a href=\"https://www.offshoreenergytoday.com/transocean-adds-158m-to-backlog-through-five-rig-deals/\" target=\"_blank\">secured a three-well contract</a> for its <em>Transocean Barents</em> semi-submersible rig at a $285K dayrate, with three one-well options.</li><li>In Egypt, the <em>Discoverer India</em> drillship was awarded a 120-day contract at a $135K dayrate, plus six one-well options.</li><li>In the Gulf of Mexico, the <em>Deepwater Asgard</em> ultra-deepwater rig won a two-well contract at a $185K dayrate.</li><li>Also, options were exercised for the <em>Leiv Eriksson</em> semi-submersible in the North Sea and the <em>Dhirubhai Deepwater KG1</em> drillship operating off India.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482369\" data-linked=\"Transocean wins five rig deals, adding $158M to backlog\" data-tweet=\"$RIG - Transocean wins five rig deals, adding $158M to backlog https://seekingalpha.com/news/3482369-transocean-wins-five-rig-deals-adding-158m-to-backlog?source=tweet\" data-url=\"https://seekingalpha.com/news/3482369-transocean-wins-five-rig-deals-adding-158m-to-backlog\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482365\" data-ts=\"1564151617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482365-analysts-lift-proofpoint-targets-after-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts lift Proofpoint targets after beat</a></h4><ul><li>Analysts boost Proofpoint's (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) targets after yesterday's <a href=\"https://seekingalpha.com/news/3482122-proofpoint-boosts-full-year-guidance-q2-beat\" target=\"_blank\">Q2 beat</a> and raised FY outlook.</li><li>Dougherty (Buy) raises PFPT from $140 to $150 citing \"a convergence of multiple strong tailwinds.\"</li><li>Piper Jaffray (Overweight) adjusts from $140 to $145, saying that Proofpoint \"continues to extend its lead in terms of market share over Microsoft and others, though annual revenue growth is clearly slowing.\"</li><li>PFPT shares are <font color=\"green\">up 3.5%</font> to $131.50. The company has a Buy <a href=\"https://seekingalpha.com/symbol/PFPT?s=pfpt\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482365\" data-linked=\"Analysts lift Proofpoint targets after beat\" data-tweet=\"$PFPT - Analysts lift Proofpoint targets after beat https://seekingalpha.com/news/3482365-analysts-lift-proofpoint-targets-after-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3482365-analysts-lift-proofpoint-targets-after-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482364\" data-ts=\"1564151462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBIO\" target=\"_blank\">HBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482364-harvard-bio-up-25-after-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvard Bio up 25% after Q2 beat</a></h4><ul><li>Nano cap Harvard Biosciences (<a href='https://seekingalpha.com/symbol/HBIO' title='Harvard Bioscience, Inc.'>HBIO</a> <font color=\"green\">+24.6%</font>) is up on more than triple normal volume after posting better-than-expected <a href=\"https://seekingalpha.com/pr/17583466-harvard-bioscience-announces-quarter-ended-june-30-2019-financial-results\" target=\"_blank\">Q2 results</a> after the close yesterday. Highlights:</li><li>Revenues down 6% to $29.6M. Loss/share: ($0.01) from ($0.04) a year ago.</li><li>Non-GAAP net income down 34% to $1.6M.</li><li>Guidance unchanged.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481869-harvard-bioscience-eps-beats-0_05-beats-revenue\" target=\"_blank\">Harvard Bioscience EPS beats by $0.05, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482364\" data-linked=\"Harvard Bio up 25% after Q2 beat\" data-tweet=\"$HBIO - Harvard Bio up 25% after Q2 beat https://seekingalpha.com/news/3482364-harvard-bio-up-25-after-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3482364-harvard-bio-up-25-after-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482363\" data-ts=\"1564151211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INT\" target=\"_blank\">INT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482363-strong-margins-lift-world-fuel-marine-segment-profit-even-volumes-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong margins lift World Fuel marine segment profit even as volumes fall</a></h4><ul><li>World Fuel Services (<a href='https://seekingalpha.com/symbol/INT' title='World Fuel Services Corporation'>INT</a> <font color='green'>+4.5%</font>) pops to a new 52-week high after <a href=\"https://seekingalpha.com/news/3481980-world-fuel-eps-beats-0_04-misses-revenue\" target=\"_blank\">Q2 earnings</a> topped analyst expectations despite a <a href=\"https://www.spglobal.com/platts/en/market-insights/latest-news/oil/072619-world-fuels-strong-margins-boost-q2-marine-segment-profit-as-volumes-fall\" target=\"_blank\">drop in marine fuel sales volumes</a>.</li><li>Despite a 13% Y/Y drop in bunker sales volumes to 5.1M metric tons, INT says Q2 gross profit in its marine segment jumped 20% Y/Y to $36.4M, mainly due to improved performance in  its core resale operations.</li><li>Core resale margins remained solid in Q2 while the continued focus on  cost management contributed to a reduced operating expense ratio in  both Q1 and Q2, Chairman and CEO Michael Kasbar says.</li><li>INT is \"cautiously optimistic regarding the opportunity  represented by the compliance challenges facing our customers with the  adoption of the IMO 2020 sulfur  cap standards,\" and the company is engaging  with customers as they prepare for the rule.</li><li>The company also said this week that it increased its  overall unsecured credit facility to $1.8B from $1.6B and extended the term  of the credit facility to July 2024.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482363\" data-linked=\"Strong margins lift World Fuel marine segment profit even as volumes fall\" data-tweet=\"$INT - Strong margins lift World Fuel marine segment profit even as volumes fall https://seekingalpha.com/news/3482363-strong-margins-lift-world-fuel-marine-segment-profit-even-volumes-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3482363-strong-margins-lift-world-fuel-marine-segment-profit-even-volumes-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482362\" data-ts=\"1564151145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSPN\" target=\"_blank\">OSPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482362-onespanminus-7-after-misses-in-line-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneSpan -7% after misses, in-line view</a></h4><ul><li>OneSpan (NASDAQ:<a href='https://seekingalpha.com/symbol/OSPN' title='OneSpan Inc.'>OSPN</a>) <font color=\"red\">-6.9%</font> after yesterday's <a href=\"https://seekingalpha.com/news/3481872-onespan-eps-misses-0_04-misses-revenue\" target=\"_blank\">Q2 results</a> missed top and bottom line estimates.</li><li>In-line FY19 guidance has revenue of $229-237M (consensus: $232.03M) with adjusted EBITDA of $22-27M.</li><li><a href=\"https://seekingalpha.com/pr/17583486-onespan-reports-results-second-quarter-first-six-months-2019-reiterates-full-year-2019\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482362\" data-linked=\"OneSpan -7% after misses, in-line view\" data-tweet=\"$OSPN - OneSpan -7% after misses, in-line view https://seekingalpha.com/news/3482362-onespanminus-7-after-misses-in-line-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3482362-onespanminus-7-after-misses-in-line-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482361\" data-ts=\"1564151056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482361-universal-logistics-slides-6-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Logistics slides 6% post Q2 results</a></h4><ul><li>Universal Logistics (<a href='https://seekingalpha.com/symbol/ULH' title='Universal Logistics Holdings, Inc.'>ULH</a> <font color=\"red\">-5.9%</font>) reports <a href=\"https://seekingalpha.com/pr/17583673-universal-logistics-holdings-reports-second-quarter-financial-results-declares-dividends\" target=\"_blank\">Q2</a> revenue growth of 4.7% Y/Y to $383.18M.</li><li>Segment revenue: Truckload was 64.8M (-21.6% Y/Y); Brokerage 89.4M (-3.4% Y/Y); Intermodal 93.9M (+71% Y/Y); Dedicated 35.9M (+0.6% Y/Y) &amp; Value-added of 99.2M (-1% Y/Y).</li><li>Truckload Services: Number of loads 61,423 (-18% Y/Y); Average operating revenue per load, excluding fuel surcharges $937 (-4% Y/Y); Average length of haul 295 (-13.7% Y/Y); Average number of tractors were 1,525 (-14.9% Y/Y).</li><li>Brokerage Services: Number of loads 57,710 (+8.7% Y/Y); Average operating revenue per load $1,484 (-10.5% Y/Y); Average length of haul 642 (+10.3% Y/Y).</li><li>Intermodal Services: Number of loads 164,761 (+67.3% Y/Y); Average operating revenue per load, excluding fuel surcharges $500 (+1.4% Y/Y); Number of depots 14 (flat% Y/Y); Average number of tractors were 1,889 (+83.4% Y/Y).</li><li>Dedicated Services: Number of loads 151,755 (+6.7% Y/Y).</li><li>Operating margin <font color=\"green\">increased 80 bps</font> to 8% &amp; EBITDA margin <font color=\"green\">increased 170 bps</font> to 12.6%.</li><li>Cash and equivalents totalled to $6.5M and marketable securities were $9.6M.</li><li>Outstanding debt was $366.8M with Capex of $14.3M.</li><li>The Board of Directors has declared a quarterly cash dividend of $0.105 per share payable on Aug.12, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481932-universal-logistics-declares-0_105-dividend\" target=\"_blank\">Universal Logistics declares $0.105 dividend</a> (Jul. 25 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481979-universal-logistics-eps-misses-0_06-misses-revenue\" target=\"_blank\">Universal Logistics EPS misses by $0.06, misses on revenue</a> (Jul. 25 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482361\" data-linked=\"Universal Logistics slides 6% post Q2 results\" data-tweet=\"$ULH - Universal Logistics slides 6% post Q2 results https://seekingalpha.com/news/3482361-universal-logistics-slides-6-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3482361-universal-logistics-slides-6-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482360\" data-ts=\"1564150932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482360-canntrust-boots-ceo-after-negative-health-canada-audit-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust boots CEO after negative Health Canada audit; shares up 14%</a></h4><ul><li>CannTrust (<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a> <font color=\"green\">+14.4%</font>) is up modestly higher volume following its <a href=\"https://seekingalpha.com/pr/17583863-canntrust-announces-senior-leadership-changes\" target=\"_blank\">announcement </a>that it fired CEO Peter Aceto after a special committee of board members investigated the issues related to a recent <a href=\"https://seekingalpha.com/news/3476133-canntrust-15-percent-premarket-negative-regulatory-audit\" target=\"_blank\">negative audit</a> by Health Canada that caused a sell-off in shares. The committee found \"new information\" that prompted the removal of Mr. Aceto.</li><li>The board also requested and received the resignation of Chairman Eric Paul.</li><li>Special Committee Chair Robert Marcovitch will  step down to assume the CEO role on an interim basis. Board member Mark Dawber will take over as head of the committee.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482360\" data-linked=\"CannTrust boots CEO after negative Health Canada audit; shares up 14%\" data-tweet=\"$CTST - CannTrust boots CEO after negative Health Canada audit; shares up 14% https://seekingalpha.com/news/3482360-canntrust-boots-ceo-after-negative-health-canada-audit-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3482360-canntrust-boots-ceo-after-negative-health-canada-audit-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482356\" data-ts=\"1564150525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXL\" target=\"_blank\">MXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482356-maxlinearminus-8-after-downside-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MaxLinear -8% after downside outlook</a></h4><ul><li>MaxLinear (NYSE:<a href='https://seekingalpha.com/symbol/MXL' title='MaxLinear, Inc.'>MXL</a>) is <font color=\"red\">down 8.2%</font> after reporting <a href=\"https://seekingalpha.com/news/3481942-maxlinear-eps-beats-0_01-revenue-line\" target=\"_blank\">Q2 results</a> yesterday with in-line revenue and upside EPS, continuing its typical <a href=\"https://seekingalpha.com/symbol/MXL/earnings/eps_surprise_summary\" target=\"_blank\">reporting trend</a>.</li><li>The downside Q3 outlook has revenue of $77-83M versus the $86.65M consensus.</li><li><a href=\"https://seekingalpha.com/pr/17583560-maxlinear-inc-announces-second-quarter-2019-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482356\" data-linked=\"MaxLinear -8% after downside outlook\" data-tweet=\"$MXL - MaxLinear -8% after downside outlook https://seekingalpha.com/news/3482356-maxlinearminus-8-after-downside-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3482356-maxlinearminus-8-after-downside-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482355\" data-ts=\"1564150479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIX\" target=\"_blank\">FIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482355-comfort-systems-slips-11-on-q2-results-miss-and-weak-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comfort Systems slips 11% on Q2 results miss and weak margins</a></h4><ul><li>Comfort Systems (<a href='https://seekingalpha.com/symbol/FIX' title='Comfort Systems USA, Inc.'>FIX</a> <font color=\"red\">-11.7%</font>) reported Q2 revenue growth of 21% Y/Y to $650.3M; and same-store backlog of $1.28B (+12.3% Q/Q).</li><li>Q2 Gross margin <font color=\"red\">declined by 232 bps</font> to 18.5%; and operating margin <font color=\"red\">declined by 202 bps</font> to 5.5%.</li><li>Q2 Adj. EBITDA was $49.81M (-1.3% Y/Y); and margin <font color=\"red\">declined by 177 bps</font> to 7.7%.</li><li>SG&amp;A expenses were $84.51M (+18.7% Y/Y); and as percentage of revenue 13% down by 31 bps.</li><li>Cash provided by operating activities for the quarter was $25.61M, compared to $33.67M a year ago; and FCF of $19.04M.</li><li>Total backlog was $1.50B as of June 30, 2019, as compared to $1.23B as of June 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481959-comfort-systems-eps-misses-0_23-misses-revenue\" target=\"_blank\">Comfort Systems EPS misses by $0.23, misses on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482355\" data-linked=\"Comfort Systems slips 11% on Q2 results miss and weak margins\" data-tweet=\"$FIX - Comfort Systems slips 11% on Q2 results miss and weak margins https://seekingalpha.com/news/3482355-comfort-systems-slips-11-on-q2-results-miss-and-weak-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3482355-comfort-systems-slips-11-on-q2-results-miss-and-weak-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482353\" data-ts=\"1564150029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAK\" target=\"_blank\">USAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482353-spot-rate-pressure-dents-usa-truck-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spot rate pressure dents USA Truck earnings</a></h4><ul> <li>USA Truck (<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='red'>-11.3%</font>) is down sharply after reporting an operating ratio of 98.5% for Q2 vs. 96.8% a year ago amid pricing pressure.</li> <li>\"The second quarter of 2019 was a challenge due to the softer freight environment, declining spot rates and unrealized bid awards. These factors combined to put pressure on our performance,\" notes USA Truck CEO James Reed.</li> <li>Base revenue per available tractor was down 2.9% Y/Y during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481963-usa-truck-eps-misses-0_20-misses-revenue\" target=\"_blank\">USA Truck EPS misses by $0.20, misses on revenue</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482353\" data-linked=\"Spot rate pressure dents USA Truck earnings\" data-tweet=\"$USAK - Spot rate pressure dents USA Truck earnings https://seekingalpha.com/news/3482353-spot-rate-pressure-dents-usa-truck-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3482353-spot-rate-pressure-dents-usa-truck-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482351\" data-ts=\"1564149593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTS\" target=\"_blank\">VRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482351-virtus-investmentplus-3_4-q2-eps-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Virtus Investment +3.4% as Q2 EPS beats</a></h4><ul><li>Virtus Investment Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTS' title='Virtus Investment Partners, Inc.'>VRTS</a>) <font color=\"green\">gains 3.4%</font> after <a href=\"https://seekingalpha.com/pr/17584031-virtus-investment-partners-announces-financial-results-second-quarter-2019\" target=\"_blank\">Q2 adjusted EPS</a> of $3.63 beat the average analyst estimate of $3.49; increased from $2.73 in Q1 and $3.36 in the year-ago quarter.</li><li>Q2 revenue of $140.5M misses consensus of $144.9M; compares with $130.7M in Q1 and $132.9M in Q2 2018.</li><li>Q2 adjusted operating margin of 36.1% compares with 29.8% in Q1 and 34.0% in the year-ago quarter.</li><li>Q2 net flows of $0.1B compares with net outflows of $0.1B in Q1 and net inflows of $1.3B in Q2 2018.</li><li>Long-term assets under management increased 3% to $103.3B at June 30, 2019 from $99.9B at March 31, 2019 as a result of market appreciation and modestly positive net inflows.</li><li><a href=\"http://ir.virtus.com/presentations\" target=\"_blank\">Conference call </a>at 10:00 Am ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3482214-virtus-investment-eps-beats-0_14-misses-revenue\" target=\"_blank\">Virtus Investment EPS beats by $0.14, misses on revenue</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482351\" data-linked=\"Virtus Investment +3.4% as Q2 EPS beats\" data-tweet=\"$VRTS - Virtus Investment +3.4% as Q2 EPS beats https://seekingalpha.com/news/3482351-virtus-investmentplus-3_4-q2-eps-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3482351-virtus-investmentplus-3_4-q2-eps-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482350\" data-ts=\"1564149540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALK\" target=\"_blank\">ALK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482350-alaska-air-gains-after-guidance-satisfies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alaska Air gains after guidance satisfies</a></h4><ul> <li>Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='green'>+0.8%</font>) trades higher after besting estimates with its Q2 report.</li> <li>The airline company reports load factor improved 20 basis points during the quarter to 86.2% on revenue passenger mile growth of 1.1%.</li> <li>For Q3, Alaska Air anticipates unti revenue growth of 2.0% to 5.0% and cost per available seat mile growth of ~5.0%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481875-alaska-air-eps-beats-0_04-beats-revenue\" target=\"_blank\">Alaska Air EPS beats by $0.04, beats on revenue</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482350\" data-linked=\"Alaska Air gains after guidance satisfies\" data-tweet=\"$ALK - Alaska Air gains after guidance satisfies https://seekingalpha.com/news/3482350-alaska-air-gains-after-guidance-satisfies?source=tweet\" data-url=\"https://seekingalpha.com/news/3482350-alaska-air-gains-after-guidance-satisfies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482346\" data-ts=\"1564149046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIAJF\" target=\"_blank\">TIAJF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482346-vodafone-telecom-italia-wrap-network-sharing-tower-agreements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone, Telecom Italia wrap network sharing, tower agreements</a></h4><ul>    <li>Vodafone (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"green\">+9.7%</font>) has confirmed and finalized its network sharing deal with Telecom Italia (<a href='https://seekingalpha.com/symbol/TIAJF' title='Telecom Italia S.p.A.'>OTCPK:TIAJF</a>), and will <a href=\"https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3628544&amp;lang=en-GB&amp;companycode=uk-vod&amp;v=\" target=\"_blank\">merge its passive towers</a> into TI's Inwit unit.</li>    <li>Vodafone will get cash consideration of \u20ac2.14B along with a 37.5% shareholding in the combination (which is valued at \u20ac3.13B, implying enterprise value for Vodafone Italy towers of \u20ac5.27B).</li>    <li>The two companies will recapitalize Inwit up to a maximum of 6x net debt. Vodafone will use cash proceeds from that and the combination deal to retire existing debt.</li>    <li>They'll retain joint control of the new Inwit, but over time will look at reducing their respective stakes from 37.5% to a minimum of 25% each.</li>    <li>The deal came in ahead of the <a href=\"https://seekingalpha.com/news/3478560-telecom-italia-chief-seeks-quick-vodafone-deal-inwit\" target=\"_blank\">Aug. 1 deadline</a> that TI CEO Luigi Gubitosi was pursuing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482346\" data-linked=\"Vodafone, Telecom Italia wrap network sharing, tower agreements\" data-tweet=\"$TIAJF $VOD $TI.A - Vodafone, Telecom Italia wrap network sharing, tower agreements https://seekingalpha.com/news/3482346-vodafone-telecom-italia-wrap-network-sharing-tower-agreements?source=tweet\" data-url=\"https://seekingalpha.com/news/3482346-vodafone-telecom-italia-wrap-network-sharing-tower-agreements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482345\" data-ts=\"1564148972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482345-solid-bio-up-13-on-60m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Bio up 13% on $60M capital raise</a></h4><ul><li>Solid Biosciences (<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences Inc.'>SLDB</a> <font color=\"green\">+12.9%</font>) is up in early trade in reaction to its <a href=\"https://seekingalpha.com/pr/17584058-solid-biosciences-announces-60-million-private-placement-new-existing-investors\" target=\"_blank\">private placement</a> of ~10.6M common shares at $4.65 per share and ~2.3M pre-funded warrants at $4.64 per warrant. Gross proceeds will be $60M. Closing date is July 30.</li><li>Net proceeds will fund the advancement of SGT-001, working capital and general corporate purposes.</li><li>Yesterday's close was $4.33.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482345\" data-linked=\"Solid Bio up 13% on $60M capital raise\" data-tweet=\"$SLDB - Solid Bio up 13% on $60M capital raise https://seekingalpha.com/news/3482345-solid-bio-up-13-on-60m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3482345-solid-bio-up-13-on-60m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482344\" data-ts=\"1564148776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYPE\" target=\"_blank\">TYPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482344-monotypeplus-23-on-825m-acquisition-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monotype +23% on $825M acquisition offer</a></h4><ul><li>Monotype Imaging (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"green\">+23.7%</font> <a href=\"https://seekingalpha.com/pr/17584023-monotype-acquired-hggc-19_85-per-share-cash\" target=\"_blank\">enters</a> into a definitive agreement with PE firm HGGC to be acquired for $19.85/share in cash.</li><li>TYPE has a 30-day go-shop period to consider other offers. Otherwise, the deal is expected to close in Q4.</li><li>The transaction has an enterprise value of approximately $825M.</li><li>The per share consideration represents a 23% premium to TYPE's closing price yesterday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482344\" data-linked=\"Monotype +23% on $825M acquisition offer\" data-tweet=\"$TYPE - Monotype +23% on $825M acquisition offer https://seekingalpha.com/news/3482344-monotypeplus-23-on-825m-acquisition-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3482344-monotypeplus-23-on-825m-acquisition-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482343\" data-ts=\"1564148684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPY\" target=\"_blank\">OPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482343-oppenheimer-gains-4_2-on-div-boost-stock-buyback-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer gains 4.2% on div boost, stock buyback, Q2 results</a></h4><ul><li>Oppenheimer Holdings (NYSE:<a href='https://seekingalpha.com/symbol/OPY' title='Oppenheimer Holdings Inc.'>OPY</a>)<font color=\"green\"> rises 4.2%</font> after announcing a dividend increase,<a href=\"https://seekingalpha.com/news/3482339-oppenheimer-holdings-may-buy-back-5-percent-class-shares\" target=\"_blank\"> a stock buyback program</a>, and higher Q2 earnings.</li><li>It will also redeem 25% of 6.75% senior notes due 2022, a move that will reduce its interest costs by $3.8M annually.</li><li><a href=\"https://seekingalpha.com/pr/17584095-oppenheimer-holdings-inc-reports-second-quarter-2019-earnings-announces-increase-quarterly\" target=\"_blank\">Q2 net income </a>of $12.4M, or 89 cents per share, increases from $8.86M, or 63 cents per share, in the year-ago quarter.</li><li>Q2 revenue of $250.9M rises 3.5% Y/Y.</li><li>Tangible book value per share of $30.62 at June 30, 2019 improved from $27.78 at June 30, 2018.</li><li>The company also boosts its quarterly dividend to 12 cents per share from 11 cents in the prior quarter.</li><li>Will redeem $50M of its 6.75% Senior Secured Notes due 2022 at a redemption price equal to 103.375% of the principal amount plus accrued and unpaid interest.</li><li>After the partial redemption, $150M principal amount of the notes will remain outstanding.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3482291-oppenheimer-holdings-reports-q2-results\" target=\"_blank\">Oppenheimer Holdings reports Q2 results</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482343\" data-linked=\"Oppenheimer gains 4.2% on div boost, stock buyback, Q2 results\" data-tweet=\"$OPY - Oppenheimer gains 4.2% on div boost, stock buyback, Q2 results https://seekingalpha.com/news/3482343-oppenheimer-gains-4_2-on-div-boost-stock-buyback-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3482343-oppenheimer-gains-4_2-on-div-boost-stock-buyback-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482341\" data-ts=\"1564148372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482341-canaccord-likes-crispr-therapeutics-in-todays-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord likes CRISPR Therapeutics in today&#39;s analyst action</a></h4><ul><li>CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"green\">+0.8%</font>) initiated with Buy rating and $72 price target at Canaccord Genuity.</li><li>Cue Biopharma (<a href='https://seekingalpha.com/symbol/CUE' title='Cue Biopharma, Inc.'>CUE</a>) initiated with Outperform rating and $13 price target at Baird.</li><li>DENTSPLY SIRONA (<a href='https://seekingalpha.com/symbol/XRAY' title='DENTSPLY SIRONA Inc.'>XRAY</a> <font color=\"green\">+0.4%</font>) initiated with Neural rating and $57 price target at Evercore ISI.</li><li>Gritstone Oncology (<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology, Inc.'>GRTS</a>) initiated with Outperform rating and $17 price target at Baird.</li><li>Neon Therapeutics (<a href='https://seekingalpha.com/symbol/NTGN' title='Neon Therapeutics, Inc.'>NTGN</a>) initiated with Outperform rating and $15 price target at Baird.</li><li>Celsion (<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color=\"red\">-1.7%</font>) initiated with Buy rating and $9 price target at Brookline Capital.</li><li>West Pharmaceutical Services (<a href='https://seekingalpha.com/symbol/WST' title='West Pharmaceutical Services, Inc.'>WST</a> <font color=\"green\">+0.8%</font>) upgraded to Neutral with a $135 price target at BofA Merrill Lynch.</li><li>DaVita (<a href='https://seekingalpha.com/symbol/DVA' title='DaVita Inc.'>DVA</a> <font color=\"green\">+0.2%</font>) downgraded to Neutral with a $65 price target at Baird.</li><li>Merit Medical Systems (<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a> <font color=\"red\">-26.1%</font>) downgraded to Market Perform with a $46 price target at Wells Fargo.</li><li>Novocure (<a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure Limited'>NVCR</a> <font color=\"red\">-0.4%</font>) downgraded to Neutral with a $79 price target at JPMorgan.</li><li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='red'>-4%</font>) downgraded to Neutral with a $4 price target at Mizuho.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482341\" data-linked=\"Canaccord likes CRISPR Therapeutics in today&#39;s analyst action\" data-tweet=\"$CRSP $CUE $XRAY - Canaccord likes CRISPR Therapeutics in today&#39;s analyst action https://seekingalpha.com/news/3482341-canaccord-likes-crispr-therapeutics-in-todays-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3482341-canaccord-likes-crispr-therapeutics-in-todays-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482335\" data-ts=\"1564147681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482335-ocular-therapeutix-up-6-premarket-on-dextenza-reimbursement-code\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular Therapeutix up 6% premarket on Dextenza reimbursement code</a></h4><ul><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) is up <font color=\"green\">6%</font> premarket on average volume in reaction to the establishment of a specific Medicare <a href=\"https://seekingalpha.com/pr/17584108-ocular-therapeutix-announces-early-assignment-permanent-specific-j-code-j1096-dextenza\" target=\"_blank\">reimbursement code</a> for DEXTENZA (dexamethasone ophthalmic insert). The code will take effect on October 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482335\" data-linked=\"Ocular Therapeutix up 6% premarket on Dextenza reimbursement code\" data-tweet=\"$OCUL - Ocular Therapeutix up 6% premarket on Dextenza reimbursement code https://seekingalpha.com/news/3482335-ocular-therapeutix-up-6-premarket-on-dextenza-reimbursement-code?source=tweet\" data-url=\"https://seekingalpha.com/news/3482335-ocular-therapeutix-up-6-premarket-on-dextenza-reimbursement-code\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482328\" data-ts=\"1564147299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482328-chtr-cur-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHTR, CUR among premarket losers</a></h4><ul><li>Neuralstem (NASDAQ:<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a>) <font color=\"red\">-39%</font> on <a href=\"https://seekingalpha.com/news/3482169-neuralstem-prices-7_5m-underwritten-public-offering-shares-33-percent-premarket\" target=\"_blank\">pricing</a> of equity offering.</li><li>Carbonite (NASDAQ:<a href='https://seekingalpha.com/symbol/CARB' title='Carbonite, Inc.'>CARB</a>) <font color=\"red\">-24%</font> on <a href=\"https://seekingalpha.com/news/3481950-carbonite-eps-beats-0_10-misses-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3482207-obalon-readies-stock-offering-shares-16-percent-premarket\" target=\"_blank\">stock offering</a>.</li><li>The Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3482276-goodyear-tire-and-rubber-eps-misses-0_09-misses-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Charter Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3482208-charter-communications-eps-misses-0_43-misses-revenue\" target=\"_blank\">Q2 results</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482328\" data-linked=\"CHTR, CUR among premarket losers\" data-tweet=\"$SNCA $CARB $OBLN - CHTR, CUR among premarket losers https://seekingalpha.com/news/3482328-chtr-cur-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482328-chtr-cur-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482324\" data-ts=\"1564147045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482324-post-earnings-rally-for-boston-beer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally for Boston Beer</a></h4><ul> <li>Boston Beer (NYSE:<a href='https://seekingalpha.com/symbol/SAM' title='The Boston Beer Company, Inc.'>SAM</a>) tracks higher after cruising past consensus estimates with its Q2 report.</li> <li>Notably, shipment volume was up 17% during the quarter and depletions were up by the same pace.</li> <li>Looking ahead, Boston Beer guides for full-year EPS of $8.30 to $9.30 vs. $8.00 to $9.00 prior view and $8.86 consensus.</li> <li>SAM <font color=\"green\">+2.24%</font> premarket to $395.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481978-boston-beer-eps-beats-0_29-beats-revenue\" target=\"_blank\">Boston Beer EPS beats by $0.29, beats on revenue</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482324\" data-linked=\"Post-earnings rally for Boston Beer\" data-tweet=\"$SAM - Post-earnings rally for Boston Beer https://seekingalpha.com/news/3482324-post-earnings-rally-for-boston-beer?source=tweet\" data-url=\"https://seekingalpha.com/news/3482324-post-earnings-rally-for-boston-beer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482323\" data-ts=\"1564147022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482323-earnings-dominate-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings dominate premarket gainers</a></h4><ul><li>Smith Micro Software (NASDAQ:<a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a>) <font color=\"green\">+35%</font> on <a href=\"https://seekingalpha.com/news/3481917-smith-micro-software-eps-beats-0_06-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Monotype Imaging Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"green\">+23%</font> on <a href=\"https://seekingalpha.com/news/3482217-monotype-imaging-eps-beats-0_10-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/news/3481965-ehealth-eps-beats-0_46-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3482296-health-insurance-innovations-explore-possible-sale-shares-16-percent-premarket\" target=\"_blank\">exploring</a> possible sale.</li><li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"green\">+10%</font>.</li><li>Vodafone Group Plc (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3482187-vodafone-group-reports-q1-trading-update\" target=\"_blank\">Q1 trading update</a>.</li><li>Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3482042-sanofi-licenses-verastems-duvelisib-certain-markets\" target=\"_blank\">agreement</a> with Sanofi.</li><li>Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3481879-alphabet-eps-beats-2_75-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3481879-alphabet-eps-beats-2_75-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"green\">+8%</font>.</li><li>Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) <font color=\"green\">+7%</font>.</li><li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3482205-twitter-eps-misses-0_14-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17584108-ocular-therapeutix-announces-early-assignment-permanent-specific-j-code-j1096-dextenza\" target=\"_blank\">early assignment</a> of permanent and specific J-code for Dextenza 0.4mg by the centers for medicare and medicaid services.</li><li>Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3481894-starbucks-eps-beats-0_05-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3482174-veoneer-eps-beats-0_27-beats-revenue\" target=\"_blank\">Q2 results</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482323\" data-linked=\"Earnings dominate premarket gainers\" data-tweet=\"$SMSI $TYPE $EHTH - Earnings dominate premarket gainers https://seekingalpha.com/news/3482323-earnings-dominate-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3482323-earnings-dominate-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482321\" data-ts=\"1564146896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482321-goodyear-tire-rubber-down-9-on-q2-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber down 9% on Q2 earnings miss</a></h4><ul><li>Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) reports sales down 5% in <a href=\"https://seekingalpha.com/pr/17584136-goodyear-reports-second-quarter-first-half-2019-results\" target=\"_blank\">Q2</a>, driven by unfavorable currency translation and lower volume.</li><li>Tire unit volume dropped 4% to 37.4M for the quarter.</li><li>Original equipment unit volume down 11% Y/Y, reflecting lower global vehicle production and strategic fitment choices.</li><li>Replacement tire shipments declined less than 1% Y/Y.</li><li>Segment sales: America: $1.97B (-2%); EMEA: $1.14B (-9%); Asia Pacific: $520M (-8%).</li><li>Segment operating margin: America: 6.8% (-80 bps); EMEA: 3.9% (-400 bps); Asia Pacific: 7.9% (-450 bps).</li><li>Total segment operating margin rate slipped 240 bps to 6%.</li><li>GT <font color=\"red\">-9.23%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3482276-goodyear-tire-and-rubber-eps-misses-0_09-misses-revenue\" target=\"_blank\">Goodyear Tire &amp; Rubber EPS misses by $0.09, misses on revenue</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482321\" data-linked=\"Goodyear Tire &amp; Rubber down 9% on Q2 earnings miss\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber down 9% on Q2 earnings miss https://seekingalpha.com/news/3482321-goodyear-tire-rubber-down-9-on-q2-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3482321-goodyear-tire-rubber-down-9-on-q2-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482319\" data-ts=\"1564146881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHMA\" target=\"_blank\">CHMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482319-chiasma-prices-stock-offering-5_50-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chiasma prices stock offering at $5.50; shares down 2% premarket</a></h4><ul><li>Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) <a href=\"https://seekingalpha.com/pr/17584242-chiasma-announces-pricing-underwritten-public-offering-55_0-million-common-stock\" target=\"_blank\">prices </a>its public offering of 10M common shares at $5.50 per share. Underwriters over-allotment is an additional 1.5M shares. Closing date is July 30.</li><li>Yesterday's close was $5.66.</li><li>Shares are down <font color=\"red\">2%</font> premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482319\" data-linked=\"Chiasma prices stock offering at $5.50; shares down 2% premarket\" data-tweet=\"$CHMA - Chiasma prices stock offering at $5.50; shares down 2% premarket https://seekingalpha.com/news/3482319-chiasma-prices-stock-offering-5_50-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3482319-chiasma-prices-stock-offering-5_50-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482316\" data-ts=\"1564146696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482316-baml-expects-starbucks-rally-to-extend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML expects Starbucks rally to extend</a></h4><ul> <li>Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) is on track to open at a new all-time high after an earnings report that featured broad-based strong comparable sales growth.</li> <li>Analysts are giving the company credit for pulling the right levers, including slowing down unit growth.</li> <li>Bank of America Merrill Lynch addresses the key issue of valuation now that SBUX is up +75% over the last 52 weeks. \"We raise our price objective to $103 (from $100), or 31x CY\u201920 P/E. This is a step-up from our prior 30x to reflect better than expected comps. SBUX has historically traded in an 18x-31x forward P/E multiple range and we expect the stock to trade towards the higher end of this range,\" writes the BAML analyst team.</li> <li>Shares of Starbucks are <font color=\"green\">up 5.95%</font> premarket to $96.36.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481894-starbucks-eps-beats-0_05-beats-revenue\" target=\"_blank\">Starbucks EPS beats by $0.05, beats on revenue</a> (July 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481970-starbucks-plus-6-percent-comp-sales-dazzle\" target=\"_blank\">Starbucks +6% after comp sales dazzle</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482316\" data-linked=\"BAML expects Starbucks rally to extend\" data-tweet=\"$SBUX - BAML expects Starbucks rally to extend https://seekingalpha.com/news/3482316-baml-expects-starbucks-rally-to-extend?source=tweet\" data-url=\"https://seekingalpha.com/news/3482316-baml-expects-starbucks-rally-to-extend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482309\" data-ts=\"1564146400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482309-cibc-softens-view-on-aphria-shares-slip-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIBC softens view on Aphria; shares slip 3% premarket</a></h4><ul><li>Cannabis products producer Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) is down <font color=\"red\">3% </font>premarket on light volume on the heels of downgrade to Neutral at CIBC. Analyst John Zamparo cites a leadership void, overly aggressive Street estimates, potential asset write-downs and less robust supply contracts.</li><li>SA Authors rate the stock <a href=\"https://seekingalpha.com/symbol/APHA/ratings/author-ratings#filter=all\" target=\"_blank\">Neutral</a>. Quant rating is <a href=\"https://seekingalpha.com/symbol/APHA/ratings/quant-ratings\" target=\"_blank\">Very Bearish</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482309\" data-linked=\"CIBC softens view on Aphria; shares slip 3% premarket\" data-tweet=\"$APHA - CIBC softens view on Aphria; shares slip 3% premarket https://seekingalpha.com/news/3482309-cibc-softens-view-on-aphria-shares-slip-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3482309-cibc-softens-view-on-aphria-shares-slip-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482304\" data-ts=\"1564145899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMSI\" target=\"_blank\">MMSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482304-merit-medical-q2-miss-and-guidance-cut-pressure-shares-down-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merit Medical Q2 miss and guidance cut pressure shares, down 17% premarket</a></h4><ul><li>Merit Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a>) slumps <font color=\"red\">17%</font> premarket, albeit on light volume, following its <a href=\"https://seekingalpha.com/pr/17583500-merit-medical-reports-earnings-second-quarter-2019\" target=\"_blank\">Q2 report</a> released after the close yesterday. Highlights:</li><li>Revenue up 14% to $255.5M, net income down 37% to $6.9M.</li><li>EPS down 43% to $0.12, non-GAAP EPS down 2% to $0.42.</li><li><strong>2019 guidance</strong>: Revenue: $1,007M - 1,029M from $1,011M - 1,030M; EPS: $0.62 - 0.84 from $1.02 - 1.13; non-GAAP EPS: $1.74 - 1.97 from $1.97 - 2.08.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481878-merit-medical-systems-eps-misses-0_08-misses-revenue\" target=\"_blank\">Merit Medical Systems EPS misses by $0.08, misses on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482304\" data-linked=\"Merit Medical Q2 miss and guidance cut pressure shares, down 17% premarket\" data-tweet=\"$MMSI - Merit Medical Q2 miss and guidance cut pressure shares, down 17% premarket https://seekingalpha.com/news/3482304-merit-medical-q2-miss-and-guidance-cut-pressure-shares-down-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3482304-merit-medical-q2-miss-and-guidance-cut-pressure-shares-down-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482301\" data-ts=\"1564145679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482301-analysts-raise-alphabet-targets-after-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Alphabet targets after beats</a></h4><ul><li>UBS raises its Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a>) <font color=\"green\">+8.6%</font> target by $25 to $1,425 after yesterday's <a href=\"https://seekingalpha.com/news/3481949-alphabet-plus-7-percent-q2-beats-25b-buyback\" target=\"_blank\">earnings repor</a>t. The firm says Alphabet \"checked every investor box\" with intact long-term drivers.</li><li>Benchmark increases GOOG from $1,315 to $1,360 saying the company should trade at a healthy premium to the market and tech sector.</li><li>Pivotal raises from $1,250 to $1,350 but stays on the sidelines as Alphabet is at the greatest risk of a Department of Justice antitrust review.</li><li>Alphabet has an Outperform <a href=\"https://seekingalpha.com/symbol/GOOG/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482301\" data-linked=\"Analysts raise Alphabet targets after beats\" data-tweet=\"$GOOG - Analysts raise Alphabet targets after beats https://seekingalpha.com/news/3482301-analysts-raise-alphabet-targets-after-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3482301-analysts-raise-alphabet-targets-after-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482297\" data-ts=\"1564145229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482297-intel-targets-raised-amd-remains-concern\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel targets raised, AMD remains concern</a></h4><ul><li>Analysts were tepid on Intel's (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"green\">+4% </font><a href=\"https://seekingalpha.com/news/3481997-intel-plus-6-percent-apples-1b-purchase-raised-fy-view\" target=\"_blank\">Q2 beats</a>, FY revenue outlook increase, and $1B smartphone modem sale to Apple. Competition from AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>)<font color=\"green\"> +1.1%</font> remains a primary concern.</li><li>Oppenheimer's Richard Schafer (Perform rating) notes that the raised FY19 guidance suggests a weaker H2 after accounting for the Q2 beat. He says the $1B sale of the smartphone modem business to Apple removes an EPS/FCF drag on Intel, but won't be accretive since any cost savings will go towards pulling in 7nm/10nm investments to prevent further share loss.</li><li>Credit Suisse's John Pitze sees Intel as underappreciated and weighed down with unnecessary investor concerns. Pitze thinks the share losses are manageable due to increased R&amp;D spend. He sees AI and machine learning as driving overall compute TAM to over $200B from this year's $90B.</li><li>Intel gets a slate of price target changes: BofAML from $57 to $62, SunTrust from $54 to $58, and Mizuho from $52 to $58, to name a few.</li><li>Intel has a Hold <a href=\"https://seekingalpha.com/symbol/INTC/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482297\" data-linked=\"Intel targets raised, AMD remains concern\" data-tweet=\"$INTC $AMD - Intel targets raised, AMD remains concern https://seekingalpha.com/news/3482297-intel-targets-raised-amd-remains-concern?source=tweet\" data-url=\"https://seekingalpha.com/news/3482297-intel-targets-raised-amd-remains-concern\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>244&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482296\" data-ts=\"1564145076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482296-health-insurance-innovations-to-explore-possible-sale-shares-up-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations to explore possible sale; shares up 16% premarket</a></h4><ul><li>Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a>) is up <font color=\"green\">16%</font> premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17584158-health-insurance-innovations-inc-announces-exploration-strategic-alternatives\" target=\"_blank\">announcement </a>that the board will explore strategic alternatives aimed at boosting shareholder value, including a possible sale of the company.</li><li>Band of America Merrill Lynch is advising.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482296\" data-linked=\"Health Insurance Innovations to explore possible sale; shares up 16% premarket\" data-tweet=\"$HIIQ - Health Insurance Innovations to explore possible sale; shares up 16% premarket https://seekingalpha.com/news/3482296-health-insurance-innovations-to-explore-possible-sale-shares-up-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3482296-health-insurance-innovations-to-explore-possible-sale-shares-up-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482293\" data-ts=\"1564144844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482293-mgm-resorts-not-interested-in-caesars-properties\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM Resorts not interested in Caesars properties</a></h4><ul> <li>MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) CEO James Murren indicated on the company's earnings call that MGM is more <a href=\"https://www.cdcgamingreports.com/mgm-resorts-not-planning-to-buy-or-sell-casinos-as-board-committee-continues-real-estate-evaluation/\" target=\"_blank\">focused</a> on its own casino portfolio than looking at add properties.</li> <li>Murren stated that MGM didn't look at Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment Corporation'>CZR</a>) properties before the Eldorado deal or after. He also noted that MGM's real estate committee has very clear guideposts with its evaluation of potential moves and expects an update in the fall.</li> <li><a href=\"https://seekingalpha.com/article/4277878-mgm-resorts-international-mgm-ceo-james-murren-q2-2019-results-earnings-call-transcript\" target=\"_blank\">MGM earnings call transcript</a></li> <li>Shares of MGM are <font color=\"green\">up 3.88%</font> premarket to $30.51.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482293\" data-linked=\"MGM Resorts not interested in Caesars properties\" data-tweet=\"$MGM $CZR - MGM Resorts not interested in Caesars properties https://seekingalpha.com/news/3482293-mgm-resorts-not-interested-in-caesars-properties?source=tweet\" data-url=\"https://seekingalpha.com/news/3482293-mgm-resorts-not-interested-in-caesars-properties\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482290\" data-ts=\"1564144736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITW\" target=\"_blank\">ITW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482290-illinois-tool-misses-q2-numbers-cuts-full-year-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illinois Tool misses Q2 numbers, cuts full-year revenue guidance</a></h4><ul><li>Illinois Tool Works (NYSE:<a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a>) <font color=\"red\">-3.8%</font> pre-market after missing <a href=\"https://seekingalpha.com/news/3482263-illinois-tool-works-eps-beats-0_02-misses-revenue\" target=\"_blank\">Q2 earnings</a> expectations as revenues of $3.61B fell 5.8% Y/Y and down 2.8% organically while also lowering full-year guidance to <a href=\"https://www.marketwatch.com/story/illinois-tool-works-shares-slump-premarket-after-earnings-miss-and-lowered-guidance-2019-07-26\" target=\"_blank\">reflect soft demand</a>.</li><li>ITW issues downside guidance for FY 2019, seeing EPS of $7.55-$7.85 vs. $7.90 analyst consensus estimate, and cuts guidance for full-year organic revenue to a 1%-3% decline vs. a prior outlook for 0.5%-2.5% growth.</li><li>ITW says it \"experienced a deceleration in demand across our portfolio relative to the demand levels we were seeing exiting the first quarter,\" adding that the company still foresees a strong H2 but adjusts guidance to better reflect the demand environment.</li><li>It is now expecting full-year EPS of $7.55 to $7.85, below the $7.88 FactSet consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482290\" data-linked=\"Illinois Tool misses Q2 numbers, cuts full-year revenue guidance\" data-tweet=\"$ITW - Illinois Tool misses Q2 numbers, cuts full-year revenue guidance https://seekingalpha.com/news/3482290-illinois-tool-misses-q2-numbers-cuts-full-year-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3482290-illinois-tool-misses-q2-numbers-cuts-full-year-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482288\" data-ts=\"1564144639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482288-ehealth-q2-top-line-up-101-guidance-raised-shares-ahead-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EHealth Q2 top line up 101%; guidance raised; shares ahead 14% premarket</a></h4><ul><li>EHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) is up <font color=\"green\">14%</font> premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17583612-ehealth-inc-announces-second-quarter-2019-results\" target=\"_blank\">Q2 results</a> released after the close yesterday. Highlights:</li><li>Revenue up 101% to $65.8M, Medicare segment up 105% to $52.3M, Individual, Family and Small Business segment up 88% to $13.5M.</li><li>Non-GAAP EBITDA: $0.8M.</li><li>Cash consumption: $11.5M.</li><li><strong>2019 guidance</strong>: Revenue: $365M - 385M from $315M - 335M; Medicare segment: $318M - 333M from $281M - 297M; Individual, Family and Small Business segment: $47M - 52M from $34M - 38M; net income: $15.5M - 20.5M from $15.0M - 20.0M; ; non-GAAP EBITDA: $65M - 70M from $55M - 60M; EPS: $0.62 - 0.82 from $0.60 - 0.79; non-GAAP EPS: $1.77 - 1.97 from $1.54 - 1.73.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481965-ehealth-eps-beats-0_46-beats-revenue\" target=\"_blank\">eHealth EPS beats by $0.46, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482288\" data-linked=\"EHealth Q2 top line up 101%; guidance raised; shares ahead 14% premarket\" data-tweet=\"$EHTH - EHealth Q2 top line up 101%; guidance raised; shares ahead 14% premarket https://seekingalpha.com/news/3482288-ehealth-q2-top-line-up-101-guidance-raised-shares-ahead-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3482288-ehealth-q2-top-line-up-101-guidance-raised-shares-ahead-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482284\" data-ts=\"1564144516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHK\" target=\"_blank\">MHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482284-on-mohawk-industries-q2-results-shares-down-10-pre-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Mohawk Industries  Q2 results; shares down 10% pre-market</a></h4><ul><li>Mohawk Industries (NYSE:<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries, Inc.'>MHK</a>)<font color=\"red\"> down 10%</font> pre-market after reporting Q2 net sales of $2.58B, a slight increase of 0.3% Y/Y. Company says most markets they operate in remain soft, with pressure on volume and pricing, and they anticipate the environment to remain difficult.</li><li>Sales by segments: Global Ceramic $958.03M (+3.1% Y/Y); Flooring NA $983.44M (-7% Y/Y); and Flooring ROW $643.02M (+8.9% Y/Y).</li><li>Q2 Gross margin<font color=\"red\"> declined by 124 bps</font> to 28.5%; and operating margin <font color=\"red\">decline by 234 bps</font> to 10.3%.</li><li>Global Ceramic Segment operating margin <font color=\"red\">declined by 217 bps to </font>12%, declining year over year due to inflation, temporary shutdown costs and marketing investments partially offset by productivity.</li><li>Q2 Adj. EBITDA was $420.18M (+20.6% Q/Q).</li><li>SG&amp;A expenses were $469.76M (+6.7% Y/Y); and as percentage of sales 18.2% up by 110 bps.</li><li>Company\u2019s net debt to adjusted EBITDA at 1.8X.</li><li>Net cash provided by operating activities was $396.19M, compared to $437.76M a year ago.</li><li>\u201cGiven the uncertainties in our markets, we are taking actions to improve our business. We are streamlining our operations, consolidating facilities and taking out higher cost assets. We are reducing production to control inventory levels, introducing new product categories and increasing promotions to address changing markets. We are reducing overhead structures and controlling investments\u201d, mentioned Jeffrey S. Lorberbaum, Chairman and CEO.</li><li><strong>3Q19 Guidance:</strong> EPS $2.58 to $2.68.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481941-mohawk-eps-beats-0_02-misses-revenue\" target=\"_blank\">Mohawk EPS beats by $0.02, misses on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3482284\" data-linked=\"More on Mohawk Industries  Q2 results; shares down 10% pre-market\" data-tweet=\"$MHK - More on Mohawk Industries Q2 results; shares down 10% pre-market https://seekingalpha.com/news/3482284-on-mohawk-industries-q2-results-shares-down-10-pre-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3482284-on-mohawk-industries-q2-results-shares-down-10-pre-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482282\" data-ts=\"1564144270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482282-mattel-execs-highlight-new-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel execs highlight new launches</a></h4><ul> <li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) is <font color=\"green\">up 6.33%</font> premarket after the company tops earnings estimates and hit its full-year cost savings target six months ahead of plan.</li> <li>The toy seller benefited from a strong quarter from the Barbie and Hot Wheels and business. During the earnings call (<a href=\"https://seekingalpha.com/article/4277903-mattel-inc-mat-ceo-ynon-kreiz-q2-2019-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), execs highlighted the global launch of Polly Pockets and upside with the BTS doll line. CEO Ynon Kreiz also explained the rationale for making movies like the Barbie film being distributed by Warner Bros.</li> <li>Shares of Mattel are trading at their highest level in over three days in the early session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481907-mattel-eps-beats-0_14-beats-revenue\" target=\"_blank\">Mattel EPS beats by $0.14, beats on revenue</a> (July 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481935-mattel-plus-5-percent-barbie-shines\" target=\"_blank\">Mattel +5% after Barbie shines</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482282\" data-linked=\"Mattel execs highlight new launches\" data-tweet=\"$MAT - Mattel execs highlight new launches https://seekingalpha.com/news/3482282-mattel-execs-highlight-new-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/3482282-mattel-execs-highlight-new-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482279\" data-ts=\"1564143761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482279-european-advisory-group-backs-novartis-lucentis-for-rare-eye-disease-in-infants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Novartis&#39; Lucentis for rare eye disease in infants</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a positive opinion <a href=\"http://www.globenewswire.com/news-release/2019/07/26/1892288/0/en/Novartis-receives-positive-CHMP-opinion-for-Lucentis-treatment-in-preterm-infants-with-retinopathy-of-prematurity-ROP-a-disease-causing-visual-impairment-and-blindness.html?culture=en-us\" target=\"_blank\">recommending approval</a> of Novartis' (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) Lucentis (ranibizumab) for the treatment of preterm infants with retinopathy of prematurity, a rare eye disorder leading to childhood blindness.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>The company in-licensed ex-U.S. rights to the VEGF inhibitor for eye diseases from Roche in 2003.</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482279\" data-linked=\"European advisory group backs Novartis&#39; Lucentis for rare eye disease in infants\" data-tweet=\"$NVS - European advisory group backs Novartis&#39; Lucentis for rare eye disease in infants https://seekingalpha.com/news/3482279-european-advisory-group-backs-novartis-lucentis-for-rare-eye-disease-in-infants?source=tweet\" data-url=\"https://seekingalpha.com/news/3482279-european-advisory-group-backs-novartis-lucentis-for-rare-eye-disease-in-infants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482275\" data-ts=\"1564143599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482275-amazon-still-star-on-wall-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon still a star on Wall Street</a></h4><ul> <li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) isn't being punished on Wall Street for forecasting operating income below expectations amid higher spending on delivery initiatives. While there's some <a href=\"https://www.cnbc.com/2019/07/26/analysts-want-more-from-amazon-after-its-mixed-earnings-report.html\" target=\"_blank\">picking</a> at the margins by the sell-side firms below, none of them moved off their Buy-equivalent ratings.</li> <li>Goldman Sachs: \"While the deceleration at AWS will raise some concerns, we continue to believe we are still relatively early-stage in the shift of workloads to the cloud, the transition of traditional retail online, and the development of the advertising business. With revenue growth accelerating, we continue to believe AMZN represents one of the best risk/rewards in Internet and remain Buy-rated (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Company'>CL</a>) with a 12-month price target of $2,400.\"</li> <li>Bank of America Merrioll Lynch: \"While higher costs are understandable, AWS revenue &amp; op. income were below estimates &amp; the one real blemish in the Q, in our view. AWS remains lumpy, and Amazon continues to add more cloud dollars than peers.\"</li> <li>Evercore ISI: \"While AMZN\u2019s investment thesis was migrating to one of growing profitability from strong top-line growth, we think this print highlights that AMZN\u2019s revenue growth acceleration story is far from dead.\"</li> <li>JPMorgan: \"Overall, the AMZN narrative has shifted back more toward top-line growth in 2019 as we expected, but the magnitude of acceleration &amp; accompanying investment spend are both bigger than we projected.\"</li> <li>Stifel: \"We are increasing our FY:19 revenue forecast as we expect continued strength in Online Stores, and lowering our FY:19 operating margin forecast to reflect the company\u2019s incremental investments in strategic areas.\"</li> <li>Shares of Amazon are <font color=\"red\">down 1.34%</font> premarket to $1,947.45 to put just a minor dent in the +30% YTD return.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481873-amazon-eps-misses-0_36-beats-revenue\" target=\"_blank\">Amazon EPS misses by $0.36, beats on revenue</a> (July 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3481902-amazon-minus-2-percent-earnings-disappoint\" target=\"_blank\">Amazon -2% after earnings disappoint</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3482275\" data-linked=\"Amazon still a star on Wall Street\" data-tweet=\"$AMZN $CL - Amazon still a star on Wall Street https://seekingalpha.com/news/3482275-amazon-still-star-on-wall-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3482275-amazon-still-star-on-wall-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3482272\" data-ts=\"1564143096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3482272-european-advisory-group-backs-alexions-soliris-for-rare-inflammatory-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Alexion&#39;s Soliris for rare inflammatory disorder</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://seekingalpha.com/pr/17584089-alexion-receives-positive-chmp-opinion-soliris-eculizumab-treatment-nmosd\" target=\"_blank\">positive opinion</a> recommending approval of Alexion Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) Soliris (eculizumab) for the treatment of adult patients with relapsing anti-aquaporin-4 (AQP4) antibody-positive <a href=\"https://rarediseases.org/rare-diseases/neuromyelitis-optica/\" target=\"_blank\">neuromyelitis optica spectrum disorder</a>, a rare autoimmune disease characterized by inflammation of the optic nerve and spinal cord.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3482272\" data-linked=\"European advisory group backs Alexion&#39;s Soliris for rare inflammatory disorder\" data-tweet=\"$ALXN - European advisory group backs Alexion&#39;s Soliris for rare inflammatory disorder https://seekingalpha.com/news/3482272-european-advisory-group-backs-alexions-soliris-for-rare-inflammatory-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3482272-european-advisory-group-backs-alexions-soliris-for-rare-inflammatory-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}